WO2008044636A1 - Anti-wrinkle agent and skin preparation for external use - Google Patents

Anti-wrinkle agent and skin preparation for external use Download PDF

Info

Publication number
WO2008044636A1
WO2008044636A1 PCT/JP2007/069569 JP2007069569W WO2008044636A1 WO 2008044636 A1 WO2008044636 A1 WO 2008044636A1 JP 2007069569 W JP2007069569 W JP 2007069569W WO 2008044636 A1 WO2008044636 A1 WO 2008044636A1
Authority
WO
WIPO (PCT)
Prior art keywords
scientific name
extract
quercus
family
acid
Prior art date
Application number
PCT/JP2007/069569
Other languages
French (fr)
Japanese (ja)
Inventor
Yukiko Matsunaga
Michio Shibata
Shunsuke Iriyama
Satoshi Amano
Ken Kusakari
Masahiro Ota
Kenichi Umishio
Original Assignee
Shiseido Company, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Company, Ltd. filed Critical Shiseido Company, Ltd.
Publication of WO2008044636A1 publication Critical patent/WO2008044636A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/49Fagaceae (Beech family), e.g. oak or chestnut
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/15Pinaceae (Pine family), e.g. pine or cedar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755Gymnosperms [Coniferophyta]
    • A61K8/9767Pinaceae [Pine family], e.g. pine or cedar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Definitions

  • the present invention relates to an anti-wrinkle agent, and in particular, suppresses and improves wrinkles, particularly fine wrinkles caused by the decrease in the function of the skin, by suppressing the thickening of the skin caused when the barrier function is decreased due to drying or the like. It relates to anti-wrinkle agents.
  • the stratum corneum located at the outermost layer of the skin protects the living body from contact and penetration of foreign substances such as bacteria and harmful substances, and keeps the skin healthy by preventing moisture evaporation from the body.
  • the barrier function decreases due to excessive water work, dry winter, and excessive cooler in summer, the transepidermal water loss (TEWU) increases from the skin surface.
  • TWU transepidermal water loss
  • stratum corneum consisting of crevice and cuticle becomes irregular due to a decrease in water content, the skin becomes bulky and rough (see Non-Patent Document 1).
  • moisturizing ingredients such as glycerin, NMF (natural moisturizing fact or) related ingredients, collagen derivatives, etc.
  • a method for increasing moisture retention of the skin by applying to the skin and a method for promoting turnover of keratinocytes using cell activation components such as bracent extract and vitamins have been proposed.
  • cell activation components such as bracent extract and vitamins
  • Non-Patent Document 1 Toshiro Sone et al., Cosmetic Society Journal Vol.15 No.2 P.60_65 (1991)
  • Non-patent document 2 Genji Ayukawa et al., Fragrance Journal 1992-11, 29-42
  • the present invention has been made in view of the above-described conventional circumstances, and an object of the present invention is to provide an anti-wrinkle agent that improves wrinkles induced when the barrier function is lowered by drying or the like, in particular, fine wrinkles. There is to do.
  • the present applicant has established an animal model (barrier destruction wrinkle model) with fine wrinkles by continuously tape stripping the hairless mouse back to reduce the noria function. .
  • the stratum corneum water content was reduced to about 60% compared to the control.
  • thickening of the epidermis and dermis is prominent, and when wrinkles recover, the thickening also subsides. Therefore, it was considered that there was a correlation between wrinkle formation and thickening of the epidermis and dermis. .
  • ADA M a disintegrin and metalloprotease having a disintegrin and meta-oral protease domain such as ADAM-9, ADAM-10, and ADAM-17.
  • ADAM Proteins belonging to the family
  • HB-EGF heparin-binding EGF-like growth factor; h sign arin-binding epidermal growth fact or-) like growth factor
  • Amphiregulin gene expression in the epidermis and by applying ADAM inhibitors, it is possible to suppress thickening and wrinkle formation of the epidermis and dermis, human or animal skin, skin
  • a test substance is brought into contact with the tissue or cell, and the enzyme activity or gene expression level of ADAM in the skin, tissue or cell is detected;
  • a method for evaluating the anti-wrinkle effect of a test substance using the enzyme generation or gene expression level of ADAM as an index has already been found (see Japanese Patent Application Nos. 2005-299524 and 2005-296219).
  • TAPI-l ⁇ N- (R)-(2- (Hydroxyaminocarbonyl) methyl) -4 -Methylpentanoyl-L-Nal-L-Alanine2-Aminoethyl amide (L_Nal: L_3_ (2 '-NaphthyOal anine) ⁇ or ⁇ TAPI-2 ⁇ N- (R)-(2- (Hydroxyaminocarbonyl) methyl) -4-Methylpentanoyl- L-t-Butyl-Glycyl-L-Alanine2-Aminoethyl amide ⁇ is known! /, The strength of these substances is not enough to inhibit ADAM, and safety as a skin external preparation has been confirmed There is a need to develop safer and more effective drugs.
  • the present inventors searched for a novel herbal medicine that inhibits ADAM activity using a cell-based ADAM inhibitor drug screening method, and examined the effect of a fine wrinkle-improving drug using a noria-destroying wrinkle model.
  • a specific herbal medicine is excellent in the action of improving fine lines, and have reached the present invention.
  • the present invention relates to Quercus lanata Sm. (Scientific name: Quercus lanata Sm.), Elaeocarpus sphaericus (scientific name: Elaeocarpus sphaericus), Quercus lineata Blume. (Scientific name: Quercus lineata Blume. ), Pinus to Orichiana A. B.
  • the present invention relates to Quercus lanata Sm. (Scientific name: Quercus lanata Sm.), Quercus lineata Blume. (Scientific name: Quercus lineata Blume.), Pinus suluciana A. b. (Scientific name: Pinus wallichiana ABJacks), Dioscorea esculenta Burkill (scientific name: Dioscorea esculenta Burkill), cinnamomum bejo noregota (scientific name: Cinnamomum bejolghota), or two or more kinds of plants selected from these An external preparation for skin characterized by comprising a solvent extract.
  • the anti-wrinkle agent of the present invention is a wrinkle induced when the barrier function is reduced by drying or the like. Prevents fine wrinkles.
  • the external preparation for skin of the present invention is capable of preventing and improving wrinkles induced when the barrier function is lowered by drying or the like, in particular fine wrinkles, and is excellent in usability and safety. is there.
  • FIG. 1 is a diagram showing measurement results of the state of wrinkle generation when the plant extract of the present invention is used.
  • FIG. 2 is a graph showing the measurement result of transepidermal water loss (TEWL) when the plant extract of the present invention is used.
  • TEWL transepidermal water loss
  • Elaeocarp sphaericus (scientific name: Elaeocarp us sphaericus) used in the present invention is a plant belonging to the genus Hortonaceae, and is referred to as holonoki, kongo, kongoju, juzubodaiju, indonesia, etc. It is known to have an active oxygen scavenging action, a hyaluronidase inhibitory action, an elastase inhibitory action, a collagenase inhibitory action, and a tyrosinase inhibitory action (see JP 2003-95857 A).
  • Quercus lineata Blume (Scientific name: Quercus lineata Blume.) Used in the present invention is called Mempening! /.
  • Quercus lanata Sm. (Scientific name: Quercus lanata Sm.) Used in the present invention is a plant belonging to the genus Quercus lanata Sm.
  • the Pinus wallichiana A.B.Jacks (Scientific name: Pinus wallichiana A.B.Jacks) used in the present invention is a plant belonging to the genus Pinus wallaceae and is called Himalayan.
  • Dioscorea esculenta Burkill (scientific name: Dioscorea esculenta Burkill) used in the present invention is a plant belonging to the genus Dioscorea esculenta Burkill, and is called the Togedoko mouth.
  • the reediosum (El.) Aarston (scientific name: Cochlospermum religiosum (Shi) Alston) used in the present invention is a general genus of the genus Tarimodokuri, yellow sik-cotton tree, silk cotton tree, yellow called cotton tree Yes.
  • Coriania nepalensis wall (scientific name: Coriari a nepalensis Wall.) Used in the present invention is a plant belonging to the genus Dokutsugi.
  • Cinnamomum bej olghota (scientific name: Cinnamomum bej olghota) used in the present invention is a plant belonging to the genus Tasnaceae.
  • Each plant used in the present invention can be used either raw or dried.
  • Elaeocarpus sphaericus (Scientific name: Elaeocarpus sphaericus) is preferred to use fruit, but other parts can also be used.
  • Quercus lineata Blume For the Quercus lineata Blume. (Scientific name: Quercus lineata Blume.) It is preferable to use the bark, but other parts can also be used.
  • Quercus lanata Sm For the beech family Quercus lanata Sm. (Scientific name: Quercus lanata Sm.), It is preferable to use seeds, but other sites can also be used.
  • Dioscorea esculenta Burkill (Scientific name: Dioscorea esculenta Burkill), bulbs are preferred, but other sites can also be used.
  • the bark beetles the bark is preferred for Cochlosper rmum religiosum (scientific name: Alston), but other parts can be used.
  • Coriania nepalensis wall (scientific name: Coriaria n mark alensis Wall.)! /, And it is preferable to use whole plants other than roots! /.
  • Cinnamomum Beshonoregota (scientific name: Cinnamomum bejolghota ritsu! /, I prefer to use bark, but other parts can also be used.
  • the solvent extract of each plant can be obtained by a conventional method, for example, together with the extraction solvent. After soaking or heating to reflux, it can be obtained by filtration and concentration.
  • the extraction solvent any solvent that is usually used for extraction can be used.
  • Organic solvents such as chloroform, formaldehyde, dichloroethane, carbon tetrachloride, acetone, ethyl acetate, hexane, etc., can be used alone or in combination.
  • Preferred as the extraction solvent are ethanol, hydrous ethanol, 1,3-butylene glycol, and hydrous 1,3-butylene glycol.
  • the extract obtained by extraction with the above solvent is used as it is, or the concentrated extract is adsorbed by a method such as removing impurities using an ion exchange resin, or a column of porous polymer (for example, Amberlite XAD-2). It is possible to use a product that has been adsorbed and then dissolved in methanol or ethanol and concentrated. Further, a partition method, for example, an extract obtained by separation / extraction with water / ethyl acetate is also used.
  • the plant extract thus obtained has an excellent ADAM activity inhibitory effect and wrinkle prevention / improving effect with high safety.
  • the anti-wrinkle agent of the present invention has a very wide application range and can be applied to various fields. Specific examples include cosmetics including quasi-drugs, pharmaceuticals, and foods.
  • the anti-wrinkle agent of the present invention is substantially a blended raw material consisting of one or more of the above plant extracts, but may contain other components. This anti-wrinkle agent is blended with the external preparation for skin to provide the external preparation for skin of the present invention.
  • the above plant extract is used in a skin external preparation, in addition to these extracts, it is usually used for a skin external preparation such as cosmetics and pharmaceuticals within the range not impairing the effects of the present invention.
  • a skin external preparation such as cosmetics and pharmaceuticals within the range not impairing the effects of the present invention.
  • Other ingredients such as oils, surfactants, alcohol, thickeners, chelating agents, active oxygen scavengers, UV absorbers, moisturizers, wetting agents, various medicinal ingredients, preservatives, neutralizers, pH adjusters Antioxidants, fragrances, water and the like can be appropriately blended as necessary.
  • the oil component includes lauryl alcohol, cetyl alcohol, Higher grades such as straight chain alcohols such as stearyl alcohol, myristinoleanolecole, oleyl alcohol, branched chain alcohols such as monostearino glycerine etherole, lanolin sanoleconole, cholesterol, and sterol alcohol
  • Higher fatty acids such as alcohol, lauric acid, myristic acid, noremitic acid, stearic acid, waxes such as solid paraffin, beeswax, hydrogenated castor oil, carnauba wax, noricowax, beef tallow, lard, sheep fat, squalane, Palm oil, palm oil, palm kernel oil, soybean oil, olive oil, cottonseed oil, jojoba oil, castor oil, lanolin and other animal and vegetable oils, liquid paraffin, petrolatum and other mineral oils, trimethylpropane triisostearate, isopropyl Myristate,
  • Surfactants include soap bases, fatty acid soaps such as sodium laurate and sodium normitate, higher alkyl sulfates such as sodium lauryl sulfate and potassium lauryl sulfate, POE lauryl sulfate triethanolamine, POE ralyl sulfate sodium, etc.
  • N-acyl sarcosine acid such as lauroyl sarcosine sodium, N-myristoyl N-methyl taurine sodium, coconut oil fatty acid methyl tauride sodium and other higher fatty acid amide sulfonic acid
  • POE stearyl ether phosphorus Phosphate esters such as acids, monolauroyl monoethanolamide, sulfosuccinates such as sodium POE sulfosuccinate, sodium lauryl polypropylene glycol sulfosuccinate, linear dodecylbenzenes Alkylbenzene sulfonates such as sodium phonate, linear dodecylbenzene sulfonate triethanolamine
  • N-acyl glutamate such as N-stearoyl glutamate monosodium, N-stearoyl glutamate monosodium, hydrogenated coconut oil fatty acid sodium glycerine sulfate
  • N-acyl glutamate such as N
  • Higher fatty acid ester sulfate ester salt, sulfated oil such as funnel oil, POE alkyl ether carboxylic acid, POE alkyl aryl ether carboxylate, higher fatty acid ester sulfonate, secondary alcohol sulfate ester salt, higher fatty acid alkylol
  • Anionic surfactants such as amidosulfuric acid ester salt, sodium lauroyl monoethanolamide succinate, sodium caseinate; Alkyltrimethylammonium salts such as tearyltrimethylammonium, lauryltrimethylammonium chloride, dialkyldimethylammonium salts such as distearyldimethylammonium chloride, alkylpyridinium salts such as cetylpyridinium chloride, Alkyl quaternary ammonium salts, alkyl dimethyl methyl benzyl ammonium salts, alkyl isoquinoline salts, dialkyl morphonium salts, POE anolequino
  • Betaine world Amphoteric surfactants such as surfactants; sorbitan monooleate, sorbitan monoisostearate, sorbitan monolaurate, sorbitan monopalmitate, sorbitan fatty acid esters such as sorbitan trioleate, mono cottonseed oil fatty acid glycerin, Glyceryl monostearate, glyceryl sesquioleate, glycerin polyglycerin fatty acids such as monostearic acid glycerin malate, propylene glycol fatty acid esters such as propylene glycol monostearate, hardened castor oil derivative, darisylene alkyl ether, ⁇ Lipophilic nonionic surfactant such as methylpolysiloxane copolymer; POE sorbitan fatty acid esters such as POE sorbitan monooleate, POE sorbitan monostearate, POE sorbit monolaurate POE sorbite fatty acid est
  • POE fatty acid esters POE lauryl ether, POE oleyl ether, POE alkyl ethers such as POE cholesterol ester, POE alkyl phenyl ethers such as POE octyl phenyl ether, POE alkyl phenyl ethers, pluroni POE, POP monobutyl ether, POE, POP alkyl ether, POE castor oil, POE hydrogenated castor oil, POE hydrogenated castor oil monoisostearate, POE hydrogenated castor oil maleic acid, etc.
  • Oil-hardened castor oil derivative POE beeswax 'lanolin derivatives such as POE sorbite beeswax, coconut oil fatty acid diethanolamide, alanol amides such as fatty acid isopropanolamide, POE propylene glycol fat
  • hydrophilic nonionic surfactants such as acid esters, POE fatty acid amides, POE anolenoleamines, sucrose fatty acid esters, and alkylethoxydimethylamine oxides.
  • alcohols include methanol, lower alcohols such as ethanol, propanol, and isopropanol, sitosterol, and lanosterol.
  • Thickeners include plant gums such as gum arabic, tragacanth gum, galactan, ginger gum, guar gum, carrageenan, pectin, agar, starch (corn, wheat, potato, rice), microorganisms such as dextran, pullulan, etc.
  • Polymers carboxymethyl starch, starch polymers such as methylhydroxypropyl starch, animal polymers such as collagen, casein, gelatin, methinoresenorelose, nitrosenorelose, ethinoresenorose, hydroxyethinoresenore Cholesterol polymers such as loin, sodium cenorelose, hydroxypropenoresenololose, canolepoxy methinorescenellose, crystalline cenorelose, algin such as sodium alginate, propylene glycol ester of alginate High molecular weight polymers, polybutyl methyl ether, bulbu polymers such as carboxybulu polymers, POE polymers, POE'POP copolymer polymers, acrylic polymers such as sodium polyacrylate and polyacryloamide, polyethylene And water-soluble polymers such as inorganic water-soluble polymers such as imine, cationic polymer, bentonite, magnesium aluminum kainate, labonite, hectorite, and an
  • Examples of the chelating agent include citramalic acid, fagaric acid, glyceric acid, shikimic acid, hinokitiol, gallic acid, tannic acid, caffeic acid, ethylenediammine tetraacetic acid, ethylene glycol diaminetetraacetic acid, diethylenetriaminepentaacetic acid, phytic acid, polyphosphorus Examples thereof include acids, metaphosphoric acids, analogs thereof, and alkali metal salts and carboxylic acid esters thereof.
  • the active oxygen scavenger superoxide dismutase, mannitol, force tarase, ⁇ -carotene, baicalin, neucarlein, hydroquinone derivative, vinorelin, cholesterol, tryptophan, histidine, taercetin, quercitrin, catechin , Catechin derivative, gallic acid, gallic acid derivative, 2 -—- ethylscorbic acid, proanthocyanidin, sesamin, epicesamine, Melissa extract, Enmeiso extract, sage extract, rosemary extract, Eloute mouth Kok extract, yew extract, jyoji extract , Kujin extract, hamamelis extract, sohakuhi extract, basil extract, ginseng extract, toki extract, gongon extract, senki extract and the like.
  • the ultraviolet absorber examples include benzoic acid-based ultraviolet absorbers such as paraaminobenzoic acid; anthranilic acid-based ultraviolet absorbers such as methyl anthranilate; salicylic acid-based ultraviolet absorbers such as octyl salicylate; Key cinnamate UV absorbers such as isopropyl acid and normethoxy key cinnamate; benzophenone UV absorbers such as 2,4-dihydroxybenzophenone and 2-hydroxy-4-methoxybenzophenone; urocanic acid and urocanic acid For example, strong ethyl ninlate.
  • humectant polyethylene glycol, propylene glycol, dipropylene glycol, 1,3-butylene glycol, glycerin, diglycerin, xylitol, maltitol, maltose, D-mannitol, glucose, fructose, chondroitin sulfate
  • examples include sodium, sodium hyaluronate, sodium lactate, darcosamine, cyclodextrin and the like.
  • Medicinal ingredients include vitamin A oil, retinol, retinol normitate, pyridoxine hydrochloride, benzyl nicotinate, nicotinamide, nicotinic acid dl—a-tocophenol, magnesium ascorbate phosphate, vitamin D2, dl — Vitamins such as ⁇ -tocopherol, pantothenic acid, biotin; anti-inflammatory agents such as azulene and glycyrrhizin; whitening agents such as arbutin; hormonal agents such as estradiol; astringents such as zinc oxide and tannic acid; L-menthol, It is possible to combine a refreshing agent such as camphor; other lysozyme chloride, pyridoxine hydrochloride, io, etc.
  • paraoxybenzoates such as methylparaben, ethylparaben, and butylparaben, benzoic acid, salicylic acid, sorbic acid, parachlormetatalesol, hexacloguchiphene, benzalkonium chloride, chlorhexidine chloride, trichloro Canolenolide, photosensitizer, phenoxyethanol and the like.
  • 1,3-propanediol, potassium hydroxide, potassium hydroxide, triethanolamine, Sodium carbonate etc. are mentioned.
  • Examples of the pH adjuster include lactic acid, citrate, glycolic acid, succinic acid, tartaric acid, malic acid, sodium hydrogen carbonate, ammonium hydrogen carbonate and the like.
  • antioxidants examples include ascorbic acid, ⁇ -tocopherol, carotenoid and the like.
  • the external preparation for skin of the present invention can be widely applied to cosmetics, pharmaceuticals, quasi-drugs and the like applied to the outer skin, and particularly preferably to cosmetics.
  • Any dosage form is applied
  • the form of use of the external preparation for skin of the present invention is also arbitrary.
  • facial cosmetics and foundations such as lotions, emulsions, tames, packs, makeup cosmetics, aromatic cosmetics, It can be used for bathing agents.
  • the form which the skin external preparation of this invention can take is not limited to said dosage form and usage form.
  • the topical skin preparation containing the agent of the present invention includes pharmaceuticals, quasi-drugs (ointments, dentifrices, etc.) and cosmetics such as facial cleansers, emulsions, creams, jewels, essences (beauty liquids), packs, It can be widely applied to basic cosmetics such as masks; makeup cosmetics such as foundations and lipsticks; oral cosmetics, aromatic cosmetics, hair cosmetics, body cosmetics and the like.
  • the form which the said skin external preparation can take is not limited to these forms.
  • the dosage form can be a wide range of dosage forms such as an aqueous solution system, a solubilization system, an oil liquid system, a gel system, an ointment system, an aerosol system, a water oil two layer system, and a water oil powder three layer system.
  • a compounding quantity is the mass%.
  • the wrinkle prevention of the present invention Demonstrate the effectiveness of the improving agent!
  • Elaeocarpus sphaericus fruit 10 ⁇ Og was immersed in 150 ml of 50% aqueous ethanol at room temperature for 1 week, the extract was filtered and the solvent was distilled off to obtain 3.3 g of 50% aqueous ethanol extract.
  • Quercus lanata Sm Seeds (10-2 g) were immersed in 100 ml of 70% aqueous ethanol at room temperature for 1 week, the extract was filtered and the solvent was distilled off to obtain 6.3 g of 70% aqueous ethanol extract.
  • Dioscorea esculenta Burkill bulb (10 g) was immersed in 100 ml of 80% ethanol aqueous solution for 1 week at room temperature, the extract was filtered and the solvent was distilled off to obtain 1.1 g of 80% ethanol aqueous extract.
  • Cinnamomum bejolghota bark 10.9 g is immersed in 150 ml of 30% 1,3-butylene glycol aqueous solution for 1 week at room temperature, the extract is filtered, the solvent is distilled off, 30% 1, 3-butylene glycol aqueous solution Extract 1.23 g was obtained.
  • HB-EGF-AP / HT-1080 (derived from human fibrosarcoma modified to forcibly express a fusion protein with the addition of thermostable alkaline phosphatase (AP) to the N-terminus of human HB-EGF)
  • the cultured cells (HT-1080) were used to screen for compounds having ADAM enzyme inhibitory activity.
  • the full-length HB-EGF molecule is expressed on the cell surface of the cell line HB-EGF-AP / HT-1080 in the form fused with alfa phosphatase! /.
  • ADAM enzymes on the cell membrane surface are activated and cleave HB-EGF molecules. Since cleaved free HB-EGF is bound with alkaline phosphatase, the ADAM enzyme inhibitory activity of the compound can be indirectly measured by measuring the alkaline phosphatase activity in the culture supernatant.
  • Table 1 Power, et al, Elaeocarpus sphaericus from the family Alasciaceae, Quercus lineata Blume. From the beech family, Quercus lanata Sm. From the pine family, Pinus wallichiana ABJacks from the pine family, Dioscorea esculenta Burkill from the pine family, Cochlosper muco m religiosum (Shi) Alston, Coriaria nepalensis Wall of Dokutsu Toshi Cinna momum bejolghota has a high inhibitory effect on HB—EGF release, suggesting that it inhibits ADAM activity.
  • TEWL measured using a water transpiration measuring device Meeco (Meeco, USA) on the left back of a hairless mouse (HR-1, male 6 week old, Hoshino experimental animal) 7 ⁇ ; Omg / m 2 / h Tape stripping 3 times a week for 4 weeks while adjusting to 1% Cochlospermum religiosum (1) Alston / ethanolol solution or 1% Que reus lanata Sm./ A 100% 70% aqueous ethanol solution was applied one by one. The n number was 6-7.
  • “Vehicle” indicates no drug (ethanol solution or 70% ethanol aqueous solution).
  • Figure 1 shows that Cochlospermum religiosum Alston ⁇ Quercus lanata Sm. Has a significant wrinkle suppression effect compared to Vehicle.
  • transepidermal water transpiration (Trans mark idermal Water Loss; TEWL) was measured using a ⁇ Vapometer (Del fm, Finland).
  • TEWL was increased by about 1.5 times the force S, 1% Cochlos permum religiosum (Lj Alston / Ethananol or 1% Quercus lanata Sm./ ⁇ 0% ethanol aqueous solution was applied. In the group, it was found that the TEWL increase caused by tape stripping was significantly suppressed.
  • Formulation examples (formulation examples) of external preparations for skin using the anti-wrinkle agent according to the present invention are shown below.
  • skin preparations for V and misalignment have excellent wrinkle prevention and improvement effects!
  • Formulation Example 2 Wrinkle prevention ⁇ Cream for improvement
  • Cinnamomum bejolghotadO% l 3 Cole extract 0 Quercus lineata Blume.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

It is intended to provide an anti-wrinkle agent which improves wrinkles, in particular fine wrinkles, induced by lowering of the skin barrier function due to drying, etc. An anti-wrinkle agent which comprises one or more plants selected from among Quercus lanata Sm. belonging to the family of Fagaceae, Elaeocarpus sphaericus belonging to the family of Elaeaocarpaceae, Quercus lineata Blume belonging to the family of Fagaceae, Pinus wallichiana A.B. Jacks belonging to the family of Pinaceae, Dioscorea esculenta Burkill belonging to the family of Dioscoreaceae, Cochlospermum religiosum (L.) Alston belonging to the family of Cochlospermaceae, Coriaria nepalensis Wall. belonging to the family of Coriariaceae and Cinnamomum bejolghota belonging to the family of Lauraceae or a solvent-extract thereof.

Description

明 細 書  Specification
抗しわ剤および皮膚外用剤  Anti-wrinkle and skin preparations
技術分野  Technical field
[0001] 本発明は、抗しわ剤に関し、特に乾燥等によりバリア機能が低下する際に惹起され る皮膚の肥厚を抑制して該ノ リア機能低下に起因するしわ、特に小じわを予防'改善 する抗しわ剤に関するものである。  [0001] The present invention relates to an anti-wrinkle agent, and in particular, suppresses and improves wrinkles, particularly fine wrinkles caused by the decrease in the function of the skin, by suppressing the thickening of the skin caused when the barrier function is decreased due to drying or the like. It relates to anti-wrinkle agents.
背景技術  Background art
[0002] 皮膚の最外層に位置する角層は細菌や有害物質などの異物の接触や浸透から生 体を保護すると共に、体内からの水分蒸散を防ぐことによって皮膚を健全な状態に保 持するバリア機能を有する。過度の水仕事や冬場の乾燥、近年では夏場のクーラー の効き過ぎ等によりバリア機能が低下すると、皮膚表面からの経表皮水分蒸発量 (tra ns epidermal water loss : TEWUが増加し、相対的に角層水分量が低下する。角層 水分量の低下により皮溝、皮丘から成る皮紋 (きめ)が不規則化すると、皮膚はかさか さした肌荒れ状態を呈する(非特許文献 1参照)。  [0002] The stratum corneum located at the outermost layer of the skin protects the living body from contact and penetration of foreign substances such as bacteria and harmful substances, and keeps the skin healthy by preventing moisture evaporation from the body. Has a barrier function. When the barrier function decreases due to excessive water work, dry winter, and excessive cooler in summer, the transepidermal water loss (TEWU) increases from the skin surface. When stratum corneum consisting of crevice and cuticle becomes irregular due to a decrease in water content, the skin becomes bulky and rough (see Non-Patent Document 1).
小じわはこの肌荒れが慢性的に続くことにより、不規則になった皮紋が一定方向に 流れてできると考えられており、実際に角層水分量の少ない肌状態の人では小じわ の面積率が高レ、ことが報告されてレ、る(非特許文献 2参照)。一般的には乾燥状態が 続くと小じわ形成が促進されるといわれている力 S、季節的な影響の他にも、現代女性 はエアコンの普及により夏場でも肌が常に乾燥した環境下に置かれており、 20代後 半あたりから小じわに対する悩みが増大する。  Minor wrinkles are thought to be caused by irregular skin crests flowing in a certain direction due to the chronic rough skin, and the area ratio of fine wrinkles is actually reduced for people with skin conditions with low stratum corneum moisture. It is reported that it is high (see Non-Patent Document 2). In general, it is said that the formation of fine lines is promoted when the dry state continues. In addition to seasonal influences, modern women are kept in a dry environment in summer due to the widespread use of air conditioners. The worries about fine wrinkles increase from the late 20s.
この皮膚バリア機能低下を防ぎ、皮膚表面からの水分蒸散、ひいては肌荒れや小 じわの発生を予防或いは改善するため、グリセリンや NMF (natural moisturizing fact or)関連成分、コラーゲン誘導体等の保湿成分を肌に塗布して皮膚の水分保持を高 める方法、ブラセンタエキス、ビタミン類などの細胞賦活成分を用いて角化細胞のタ ーンオーバーを促進する方法等が提案されている。しかしながら、老化及びしわに関 するメカニズムにつ!/、て明らかではな!/、部分が多かったため、従来の化粧料にお!/ヽ ては、前述したようなしわ改善のための水分保持に努める等の方法のみであり、それ も前述したように充分な効果を発揮してレ、なレ、のが現状である。 In order to prevent this skin barrier function deterioration and prevent or improve moisture transpiration from the skin surface, and in turn, rough skin and fine lines, moisturizing ingredients such as glycerin, NMF (natural moisturizing fact or) related ingredients, collagen derivatives, etc. A method for increasing moisture retention of the skin by applying to the skin and a method for promoting turnover of keratinocytes using cell activation components such as bracent extract and vitamins have been proposed. However, there are many mechanisms related to aging and wrinkles! /, Because there were many parts, conventional cosmetics! / It is only a way of trying, and that As described above, the present state is that it exhibits a sufficient effect.
[0003] 非特許文献 1 :曽根俊郎ら、香粧会誌 Vol.15 No.2 P.60_65(1991) [0003] Non-Patent Document 1: Toshiro Sone et al., Cosmetic Society Journal Vol.15 No.2 P.60_65 (1991)
非特許文献 2 :芋川玄爾ら、 Fragrance Journal 1992-11、 29-42  Non-patent document 2: Genji Ayukawa et al., Fragrance Journal 1992-11, 29-42
発明の開示  Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0004] 本発明は上記したような従来の事情に鑑みてなされたもので、その目的は、乾燥等 によりバリア機能が低下した際に誘導されるしわ、特に小じわを改善する抗しわ剤を 提供することにある。  [0004] The present invention has been made in view of the above-described conventional circumstances, and an object of the present invention is to provide an anti-wrinkle agent that improves wrinkles induced when the barrier function is lowered by drying or the like, in particular, fine wrinkles. There is to do.
課題を解決するための手段  Means for solving the problem
[0005] 本出願人はこれまでにへアレスマウス背部にテープストリツビングを継続的に行って ノ リア機能を低下させることによって小じわ様のしわを有する動物モデル (バリア破壊 しわモデル)を確立した。このモデル動物では角層水分量がコントロールと比較して 6 割程度に低下していた。組織では表皮および真皮肥厚が顕著で、しわが回復すると 肥厚も収まることから、しわ形成と表皮および真皮肥厚には相関性があると考えられ た (第 30回日本研究皮膚科学会にて発表)。  [0005] The present applicant has established an animal model (barrier destruction wrinkle model) with fine wrinkles by continuously tape stripping the hairless mouse back to reduce the noria function. . In this model animal, the stratum corneum water content was reduced to about 60% compared to the control. In the tissue, thickening of the epidermis and dermis is prominent, and when wrinkles recover, the thickening also subsides. Therefore, it was considered that there was a correlation between wrinkle formation and thickening of the epidermis and dermis. .
[0006] また本出願人は、ノ リア破壊しわモデルにおいて、 ADAM— 9、 ADAM— 10およ び AD AM— 17等の、デイスインテグリンとメタ口プロテアーゼドメインを有する ADA M (a disintegrin and metalloprotease)ファミリーに属するタンパク質(以下、 ADAMと 称する)、さらにはそれら ADAMによって細胞膜からの遊離および活性化がなされる HB-EGF (へパリン結合性 EGF様増殖因子; h印 arin-binding epidermal growth fact or-like growth factor)および Amphiregulinの表皮における遺伝子発現が亢進してい ること、さらにはそれら ADAMの阻害剤を塗布することによって、表皮および真皮の 肥厚ならびにしわ形成を抑制できること、ヒトまたは動物の皮膚、皮膚組織または細 胞に被験物質を接触させ、前記皮膚、組織または細胞における ADAMの酵素活性 または遺伝子発現レベルを検出し、 ADAMの酵素発生または遺伝子発現レベルを 指標として被験物質の抗しわ効果を評価する方法をすでに見出している(特願 2005 — 299524号、特願 2005— 296219号参照)。  [0006] In addition, the present applicant has also found that in a nodal destruction wrinkle model, ADA M (a disintegrin and metalloprotease) having a disintegrin and meta-oral protease domain such as ADAM-9, ADAM-10, and ADAM-17. Proteins belonging to the family (hereinafter referred to as ADAM), and HB-EGF (heparin-binding EGF-like growth factor; h sign arin-binding epidermal growth fact or-) like growth factor) and Amphiregulin gene expression in the epidermis, and by applying ADAM inhibitors, it is possible to suppress thickening and wrinkle formation of the epidermis and dermis, human or animal skin, skin A test substance is brought into contact with the tissue or cell, and the enzyme activity or gene expression level of ADAM in the skin, tissue or cell is detected; A method for evaluating the anti-wrinkle effect of a test substance using the enzyme generation or gene expression level of ADAM as an index has already been found (see Japanese Patent Application Nos. 2005-299524 and 2005-296219).
[0007] 一方、 ADAM阻害剤としては TAPI- l{N-(R)-(2-(Hydroxyaminocarbonyl)methyl)-4 -Methylpentanoyl-L-Nal-L-Alanine2-Aminoethyl amide(L_Nal:L_3_(2 ' -NaphthyOal anine)}やゝ TAPI-2{N-(R)-(2-(Hydroxyaminocarbonyl)methyl) -4-Methylpentanoyl-L -t-Butyl-Glycyl-L-Alanine2-Aminoethyl amide}が知られて!/、る力 これらの物質の ADAM阻害能は充分とは言えず、また皮膚外用剤としての安全性は確認されて!/ヽ ない。そこで、より安全で効果の高い薬剤の開発が求められてきた。 [0007] On the other hand, as an ADAM inhibitor, TAPI-l {N- (R)-(2- (Hydroxyaminocarbonyl) methyl) -4 -Methylpentanoyl-L-Nal-L-Alanine2-Aminoethyl amide (L_Nal: L_3_ (2 '-NaphthyOal anine)} or ゝ TAPI-2 {N- (R)-(2- (Hydroxyaminocarbonyl) methyl) -4-Methylpentanoyl- L-t-Butyl-Glycyl-L-Alanine2-Aminoethyl amide} is known! /, The strength of these substances is not enough to inhibit ADAM, and safety as a skin external preparation has been confirmed There is a need to develop safer and more effective drugs.
[0008] 本発明者らは、細胞を用いた ADAM阻害薬剤スクリーニング方法を用いて ADA M活性を阻害する新規な生薬を探索し、ノ リア破壊しわモデルを用いて小じわ改善 薬剤の効果を検討したところ、特定の生薬が小じわを改善する作用に優れていること を見出し、本発明に至った。  [0008] The present inventors searched for a novel herbal medicine that inhibits ADAM activity using a cell-based ADAM inhibitor drug screening method, and examined the effect of a fine wrinkle-improving drug using a noria-destroying wrinkle model. However, the present inventors have found that a specific herbal medicine is excellent in the action of improving fine lines, and have reached the present invention.
[0009] 本発明は、ブナ科のクエルカス ラナタ エスエム. (学名: Quercus lanata Sm.)、ホ ノレトノキ科のエラォカルプス スファエリカス(学名: Elaeocarpus sphaericus)、ブナ科 のクエルカス リネアタ ブルム. (学名: Quercus lineata Blume.)、マツ科のピヌス ゥ オリチアナ エー. ビー.ジャタス(学名: Pinus wallichiana A.B.Jacks )、ャマノィモ科 のディォスコレア エスクレンタ ブノレキノレ(学名: Dioscorea esculenta Burkill)、ヮタリ モドキ科のココロスペルマム レリジォスム(エル.)ァルストン(学名: Cochlospermum religiosum (し) Alston)、ドクウツギ科のコリアリア ネパレンシス ウォール(学名: Coria ria nepalensis Wall.)、クスノキ禾斗のシナモマム ベンョノレコタ ( 名: Cinnamomum bej olghota)力、ら選ばれる一種または二種以上の植物、またはこれらの溶媒抽出物を含 有することを特徴とする抗しわ剤である。  [0009] The present invention relates to Quercus lanata Sm. (Scientific name: Quercus lanata Sm.), Elaeocarpus sphaericus (scientific name: Elaeocarpus sphaericus), Quercus lineata Blume. (Scientific name: Quercus lineata Blume. ), Pinus to Orichiana A. B. Jatas (scientific name: Pinus wallichiana ABJacks), Dioscorea Escrenta Bunorekinore (scientific name: Dioscorea esculenta Burkill) Scientific name: Cochlospermum religiosum (Shi) Alston), Corian ria nepalensis Wall. (Scientific name: Cinnamomum bej olghota), one or more selected from the power of Cinnamomum bej olghota Plants, or these solvent extracts An anti-wrinkle agent characterized by having.
[0010] また本発明は、ブナ科のクエルカス ラナタ エスエム. (学名: Quercus lanata Sm.) 、ブナ科のクエルカス リネアタ ブルム. (学名: Quercus lineata Blume.)、マツ科の ピヌス ゥオリチアナ エー.ビー.ジャタス(学名: Pinus wallichiana A.B.Jacks)、ャマ ノィモ科のディォスコレア エスクレンタ ブルキル(学名: Dioscorea esculenta Burkill )、タスノキ科のシナモマム ベジョノレゴタ(学名: Cinnamomum bejolghota)から選ばれ る一種または二種以上の植物、またはこれらの溶媒抽出物を配合してなることを特徴 とする皮膚外用剤である。  [0010] Further, the present invention relates to Quercus lanata Sm. (Scientific name: Quercus lanata Sm.), Quercus lineata Blume. (Scientific name: Quercus lineata Blume.), Pinus suluciana A. b. (Scientific name: Pinus wallichiana ABJacks), Dioscorea esculenta Burkill (scientific name: Dioscorea esculenta Burkill), cinnamomum bejo noregota (scientific name: Cinnamomum bejolghota), or two or more kinds of plants selected from these An external preparation for skin characterized by comprising a solvent extract.
発明の効果  The invention's effect
[0011] 本発明の抗しわ剤は、乾燥等によりバリア機能が低下した際に誘導されるしわ、特 に小じわを防止 .改善すること力 Sできる。 [0011] The anti-wrinkle agent of the present invention is a wrinkle induced when the barrier function is reduced by drying or the like. Prevents fine wrinkles.
[0012] また本発明の皮膚外用剤は、乾燥等によりバリア機能が低下した際に誘導されるし わ、特に小じわを防止 ·改善することができ、使用性および安全性にも優れたもので ある。 [0012] Further, the external preparation for skin of the present invention is capable of preventing and improving wrinkles induced when the barrier function is lowered by drying or the like, in particular fine wrinkles, and is excellent in usability and safety. is there.
図面の簡単な説明  Brief Description of Drawings
[0013] [図 1]本発明の植物抽出物を用いた時のしわの発生状況の測定結果を示す図である [0013] FIG. 1 is a diagram showing measurement results of the state of wrinkle generation when the plant extract of the present invention is used.
Yes
[図 2]本発明の植物抽出物を用いた時の経表皮水分蒸散量(Trans印 idermal Water Loss ;TEWL)の測定結果を示す図である。  FIG. 2 is a graph showing the measurement result of transepidermal water loss (TEWL) when the plant extract of the present invention is used.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0014] 以下に、本発明の最良の実施の形態について説明する。 [0014] The best mode of the present invention will be described below.
本発明で用いられるホルトノキ科のエラォカルプス スファエリカス(学名: Elaeocarp us sphaericus)は、ホルトノキ科ホルトノキ属の植物で、ホルトノキ、金剛子、金剛珠、 ジュズボダイジュ、インドジュズノキなどと称されている。活性酸素消去作用、ヒアルロ ニダーゼ阻害作用、エラスターゼ阻害作用、コラゲナーゼ阻害作用、チロシナーゼ 阻害作用を有していることが知られている(特開 2003— 95857号公報参照)。  Elaeocarp sphaericus (scientific name: Elaeocarp us sphaericus) used in the present invention is a plant belonging to the genus Hortonaceae, and is referred to as holonoki, kongo, kongoju, juzubodaiju, indonesia, etc. It is known to have an active oxygen scavenging action, a hyaluronidase inhibitory action, an elastase inhibitory action, a collagenase inhibitory action, and a tyrosinase inhibitory action (see JP 2003-95857 A).
本発明で用いられるブナ科のクエルカス リネアタ ブルム. (学名: Quercus lineata Blume.)は、メンペンイング(Mempening)と称されて!/、る。  Quercus lineata Blume. (Scientific name: Quercus lineata Blume.) Used in the present invention is called Mempening! /.
本発明で用いられるブナ科のクエルカス ラナタ エスエム. (学名: Quercus lanata Sm.)は、ブナ科コナラ属に属する植物である。  Quercus lanata Sm. (Scientific name: Quercus lanata Sm.) Used in the present invention is a plant belonging to the genus Quercus lanata Sm.
本発明で用いられるマツ科のピヌス ゥオリチアナ エー.ビー.ジャタス(学名: Pin us wallichiana A.B.Jacks)は、マツ科マツ属の植物で、ヒマラヤゴヨウと称されている。 本発明で用いられるャマノィモ科のディォスコレア エスクレンタ ブルキル(学名: Dioscorea esculenta Burkill)は、ャマノィモ科ャマノィモ属の植物で、トゲドコ口と称さ れている。  The Pinus wallichiana A.B.Jacks (Scientific name: Pinus wallichiana A.B.Jacks) used in the present invention is a plant belonging to the genus Pinus wallaceae and is called Himalayan. Dioscorea esculenta Burkill (scientific name: Dioscorea esculenta Burkill) used in the present invention is a plant belonging to the genus Dioscorea esculenta Burkill, and is called the Togedoko mouth.
本発明で用いられるヮタリモドキ科のココロスペルマム レリジォスム(エル.)ァルス トン(学名: Cochlospermum religiosum (し) Alston)は、ヮタリモドキ科ヮタリモドキ属の 概物で、 yellow sik-cotton tree、 silk cotton tree、 yellow cotton treeなどと称 れて いる。 The reediosum (El.) Aarston (scientific name: Cochlospermum religiosum (Shi) Alston) used in the present invention is a general genus of the genus Tarimodokuri, yellow sik-cotton tree, silk cotton tree, yellow called cotton tree Yes.
本発明で用いられるドクウツギ科のコリアリア ネパレンシス ウォール(学名: Coriari a nepalensis Wall.)は、ドクウツギ科ドクゥツギ属の植物である。  Coriania nepalensis wall (scientific name: Coriari a nepalensis Wall.) Used in the present invention is a plant belonging to the genus Dokutsugi.
本発明で用いられるタスノキ科のシナモマム ベジョルゴタ(学名: Cinnamomum bej olghota)は、タスノキ科タスノキ属の植物である。  Cinnamomum bej olghota (scientific name: Cinnamomum bej olghota) used in the present invention is a plant belonging to the genus Tasnaceae.
[0015] 本発明で用いられる各植物は、生のままでも乾燥したものでも使用することができる [0015] Each plant used in the present invention can be used either raw or dried.
1 使用性、製剤化等の観点から乾燥粉末あるいは溶媒抽出物として用いることが 好ましい。  1 From the viewpoint of usability and formulation, it is preferable to use it as a dry powder or a solvent extract.
[0016] それぞれの植物を乾燥粉末あるいは溶媒抽出物とする時の好まし!/、使用部位は次 の通りである。  [0016] Preferable when each plant is used as a dry powder or solvent extract! / Used sites are as follows.
ホルトノキ科のエラォカルプス スファエリカス(学名: Elaeocarpus sphaericus)につ V、ては果実を用いるのが好ましレ、が、他の部位を用いることもできる。  For example, Elaeocarpus sphaericus (Scientific name: Elaeocarpus sphaericus) is preferred to use fruit, but other parts can also be used.
ブナ科のクエルカス リネアタ ブルム. (学名: Quercus lineata Blume.)については 樹皮を用いるのが好ましレ、が、他の部位を用いることもできる。  For the Quercus lineata Blume. (Scientific name: Quercus lineata Blume.) It is preferable to use the bark, but other parts can also be used.
ブナ科のクエルカス ラナタ エスエム. (学名: Quercus lanata Sm.)については種 子を用いるのが好ましレ、が、他の部位を用いることもできる。  For the beech family Quercus lanata Sm. (Scientific name: Quercus lanata Sm.), It is preferable to use seeds, but other sites can also be used.
マツ科のピヌス ゥオリチアナ エー.ビー.ジャタス(学名: Pinus wallichiana A.B.Ja cks)については樹皮を用いるのが好ましいが、他の部位を用いることもできる。  For the Pinus wallichiana A.B.Jacks, it is preferable to use bark, but other parts can also be used.
ャマノィモ科のディォスコレア エスクレンタ ブノレキノレ(学名: Dioscorea esculenta Burkill)については球根を用いるのが好ましいが、他の部位を用いることもできる。 ヮタリモドキ科のココロスペルマム レリジォスム(エル. )ァルストン(学名: Cochlospe rmum religiosum (し) Alston)については樹皮を用いるのが好ましいが、他の部位を用 いることあでさる。  For Dioscorea esculenta Burkill (Scientific name: Dioscorea esculenta Burkill), bulbs are preferred, but other sites can also be used. For bark beetles, the bark is preferred for Cochlosper rmum religiosum (scientific name: Alston), but other parts can be used.
ドクウツギ科のコリアリア ネパレンシス ウォール(学名: Coriaria n印 alensis Wall.) につ!/、ては根以外の全草を用いるのが好まし!/、。  Coriania nepalensis wall (scientific name: Coriaria n mark alensis Wall.)! /, And it is preferable to use whole plants other than roots! /.
クスノキ禾斗のシナモマム べショノレゴタ (学名: Cinnamomum bejolghotaリにつ!/、ては 樹皮を用いるのが好ましレ、が、他の部位を用いることもできる。  Cinnamomum Beshonoregota (scientific name: Cinnamomum bejolghota ritsu! /, I prefer to use bark, but other parts can also be used.
[0017] 上記各植物の溶媒抽出物は常法により得ることができ、例えば、抽出溶媒とともに 浸漬または加熱還流した後、濾過し濃縮して得ること力できる。抽出溶媒としては、通 常抽出に用いられる溶媒であれば任意に用いることができ、例えば、水、メタノーノレ、 エタノール、プロピレングリコール、 1 , 3—ブチレングリコール、グリセリン等のアルコ ール類、含水アルコール類、クロ口ホルム、ジクロルェタン、四塩化炭素、アセトン、酢 酸ェチル、へキサン等の有機溶媒類等を、それぞれ単独あるいは組み合わせて用 いること力 Sできる。抽出溶媒として好ましいものは、エタノール、含水エタノール、 1 , 3 ーブチレングリコール、含水 1 , 3—ブチレングリコールである。 [0017] The solvent extract of each plant can be obtained by a conventional method, for example, together with the extraction solvent. After soaking or heating to reflux, it can be obtained by filtration and concentration. As the extraction solvent, any solvent that is usually used for extraction can be used. For example, water, methanol, ethanol, propylene glycol, 1,3-butylene glycol, alcohols such as glycerin, hydrous alcohol, and the like. , Organic solvents such as chloroform, formaldehyde, dichloroethane, carbon tetrachloride, acetone, ethyl acetate, hexane, etc., can be used alone or in combination. Preferred as the extraction solvent are ethanol, hydrous ethanol, 1,3-butylene glycol, and hydrous 1,3-butylene glycol.
上記溶媒で抽出して得た抽出液をそのまま、あるいは濃縮したエキスを吸着法、例 えばイオン交換樹脂を用いて不純物を除去したものや、ポーラスポリマー(例えばァ ンバーライト XAD— 2)のカラムにて吸着させた後、メタノールまたはエタノールで溶 出し、濃縮したものも使用すること力 Sできる。また分配法、例えば水/酢酸ェチルで 分液抽出した抽出物等も用いられる。  The extract obtained by extraction with the above solvent is used as it is, or the concentrated extract is adsorbed by a method such as removing impurities using an ion exchange resin, or a column of porous polymer (for example, Amberlite XAD-2). It is possible to use a product that has been adsorbed and then dissolved in methanol or ethanol and concentrated. Further, a partition method, for example, an extract obtained by separation / extraction with water / ethyl acetate is also used.
[0018] このようにして得た上記植物抽出物は、安全性が高ぐ優れた ADAM活性阻害効 果およびしわ防止 ·改善効果を有する。本発明の抗しわ剤は極めて応用範囲が広く 、種々の分野に応用することができる。具体的には、医薬部外品を含む化粧料、医 薬品、食品等が挙げられる。  [0018] The plant extract thus obtained has an excellent ADAM activity inhibitory effect and wrinkle prevention / improving effect with high safety. The anti-wrinkle agent of the present invention has a very wide application range and can be applied to various fields. Specific examples include cosmetics including quasi-drugs, pharmaceuticals, and foods.
[0019] なお、本発明の抗しわ剤は、実質的に上記植物抽出物の一種または二種以上から なる配合原料であるが、他の成分を含んでいてもよい。この抗しわ剤が皮膚外用剤に 配合されて、本発明の皮膚外用剤が提供される。  [0019] The anti-wrinkle agent of the present invention is substantially a blended raw material consisting of one or more of the above plant extracts, but may contain other components. This anti-wrinkle agent is blended with the external preparation for skin to provide the external preparation for skin of the present invention.
[0020] 上記植物抽出物を皮膚外用剤に配合して用いる場合、外用剤全量中に乾燥重量 として 0. 000001— 5. 0質量0 /0酉己合するの力好まし <、より好まし <は 0. 00001— 3 • 0質量0 /0、特に好ましくは 0· 00001 - 1. 0質量0 /0である。 [0020] the case of a plant extract used by blending into the skin external preparation, preferably a force to 0. 000001- 5.0 mass 0/0 Rooster himself if a dry weight in the total amount of the external preparation <, more preferably <the 0. 00001- 3 • 0 mass 0/0, and particularly preferably 0 - 00001 - 1. 0 mass 0/0.
[0021] 上記植物抽出物を皮膚外用剤に配合して用いる場合、これら抽出物に加えて、本 発明の効果を損わない範囲内で、通常化粧品や医薬品等の皮膚外用剤に用いられ る他の成分、例えば油分、界面活性剤、アルコール、増粘剤、キレート剤、活性酸素 消去剤、紫外線吸収剤、保湿剤、湿潤剤、各種薬効成分、防腐剤、中和剤、 pH調 整剤、酸化防止剤、香料、水等を必要に応じて適宜配合することができる。  [0021] When the above plant extract is used in a skin external preparation, in addition to these extracts, it is usually used for a skin external preparation such as cosmetics and pharmaceuticals within the range not impairing the effects of the present invention. Other ingredients such as oils, surfactants, alcohol, thickeners, chelating agents, active oxygen scavengers, UV absorbers, moisturizers, wetting agents, various medicinal ingredients, preservatives, neutralizers, pH adjusters Antioxidants, fragrances, water and the like can be appropriately blended as necessary.
[0022] 上記任意配合成分のうち、油分としては、ラウリルアルコール、セチルアルコール、 ステアリルアルコール、ミリスチノレアノレコーノレ、ォレイルアルコール等の直鎖アルコー ノレ、モノステアリノレグリセリンエーテノレ、ラノリンサノレコーノレ、コレステロ一ノレ、フイトステ ロール、イソステアリルアルコール等の分岐鎖アルコール等の高級アルコール、ラウリ ン酸、ミリスチン酸、ノ^レミチン酸、ステアリン酸等の高級脂肪酸、固形パラフィン、ビ ースワックス、硬化ヒマシ油、カルナゥバロウ、ノ リコワックス等のワックス、牛脂、豚脂 、羊脂、スクヮラン、ヤシ油、パーム油、パーム核油、大豆油、ォリーブ油、綿実油、ホ ホバ油、ヒマシ油、ラノリン等の動植物油脂、流動パラフィン、ワセリン等の鉱物油、ト リメチルプロパントリイソステアレート、イソプロピルミリステート、グリセロールトリー 2— ェチルへキサネート、ペンタエリスリトールテトラー 2—ェチルへキサネート、環状また は直鎖シリコーン油、ポリオキシエチレン(以下、 POEとも記載する。)ポリオキシプロ ピレン (以下、 POPとも記載する。)ペンタエリスリトールエーテル等の合成油等が挙 げられる。 [0022] Among the above optional ingredients, the oil component includes lauryl alcohol, cetyl alcohol, Higher grades such as straight chain alcohols such as stearyl alcohol, myristinoleanolecole, oleyl alcohol, branched chain alcohols such as monostearino glycerine etherole, lanolin sanoleconole, cholesterol, and sterol alcohol Higher fatty acids such as alcohol, lauric acid, myristic acid, noremitic acid, stearic acid, waxes such as solid paraffin, beeswax, hydrogenated castor oil, carnauba wax, noricowax, beef tallow, lard, sheep fat, squalane, Palm oil, palm oil, palm kernel oil, soybean oil, olive oil, cottonseed oil, jojoba oil, castor oil, lanolin and other animal and vegetable oils, liquid paraffin, petrolatum and other mineral oils, trimethylpropane triisostearate, isopropyl Myristate, glycerol tri 2-Ethylhexanate, Pentaerythritol tetra-2-Ethylhexanate, Cyclic or linear silicone oil, Polyoxyethylene (hereinafter also referred to as POE) Polyoxypropylene (hereinafter also referred to as POP) Pentaerythritol ether And other synthetic oils.
界面活性剤としては、セッケン用素地、ラウリン酸ナトリウム、ノルミチン酸ナトリウム 等の脂肪酸セッケン、ラウリル硫酸ナトリウム、ラウリル硫酸カリウム等の高級アルキル 硫酸エステル塩、 POEラウリル硫酸トリエタノールァミン、 POEラルリル硫酸ナトリウム 等のアルキルエーテル硫酸エステル塩、ラウロイルサルコシンナトリゥム等の N—ァシ ルサルコシン酸、 N—ミリストイル— N—メチルタウリンナトリウム、ヤシ油脂肪酸メチル タウリツドナトリウム等の高級脂肪酸アミドスルホン酸、 POEステアリルエーテルリン酸 等のリン酸エステル塩、モノラウロイルモノエタノールアミド POEスルホコハク酸ナトリ ゥム、ラウリルポリプロピレングリコールスルホコハク酸ナトリウム等のスルホコハク酸塩 、リニアドデシルベンゼンスルホン酸ナトリウム、リニアドデシルベンゼンスルホン酸トリ エタノールァミン等のアルキルベンゼンスルホン酸塩、 N—ステアロイルグルタミン酸 ジナトリウム、 N—ステアロイルグルタミン酸モノナトリウム等の N—ァシルグルタミン酸 塩、硬化ヤシ油脂肪酸グリセリン硫酸ナトリウム等の高級脂肪酸エステル硫酸エステ ル塩、ロート油等の硫酸化油、 POEアルキルエーテルカルボン酸、 POEアルキルァ リルエーテルカルボン酸塩、高級脂肪酸エステルスルホン酸塩、二級アルコール硫 酸エステル塩、高級脂肪酸アルキロールアミド硫酸エステル塩、ラウロイルモノエタノ ールアミドコハク酸ナトリウム、カゼインナトリウム等のァニオン系界面活性剤;塩化ス テアリルトリメチルアンモニゥム、塩化ラウリルトリメチルアンモニゥム等のアルキルトリメ チルアンモニゥム塩、塩化ジステアリルジメチルアンモニゥム塩等のジアルキルジメチ ルアンモニゥム塩、塩化セチルピリジニゥム等のアルキルピリジニゥム塩、アルキル四 級アンモニゥム塩、アルキルジメチメチルベンジルアンモニゥム塩、アルキルイソキノ リニゥム塩、ジアルキルモリホニゥム塩、 POEァノレキノレアミン、ァノレキノレアミン塩、ポリ ァミン脂肪酸誘導体、ァミルアルコール脂肪酸誘導体、塩化ベンザルコニゥム等の力 チオン系界面活性剤; 2—ココイル 2—イミダゾリニゥムヒドロキシドー 1 カルボキ シェチロキシニナトリウム塩等のイミダゾリン系両性界面活性剤、アミドべタイン、スル ホべタイン等のベタイン系界面活性剤等の両性界面活性剤;ソルビタンモノォレエー ト、ソルビタンモノイソステアレート、ソルビタンモノラウレート、ソルビタンモノパルミテ ート、ソルビタントリオレエート等のソルビタン脂肪酸エステル類、モノ綿実油脂肪酸 グリセリン、モノステアリン酸グリセリン、セスキォレイン酸グリセリン、モノステアリン酸 グリセリンリンゴ酸塩等のグリセリンポリグリセリン脂肪酸類、モノステアリン酸プロピレ ングリコール等のプロピレングリコール脂肪酸エステル類、硬化ヒマシ油誘導体、ダリ セリンアルキルエーテル、 ΡΟΕ·メチルポリシロキサン共重合体等の親油性非イオン 界面活性剤; POEソルビタンモノォレエート、 POEソルビタンモノステアレート等の P OEソルビタン脂肪酸エステル類、 POEソルビットモノラウレート、 POEソルビットモノ ォレエート、 POEソルビットモノステアレート等の POEソルビット脂肪酸エステル類、 P OEグリセリンモノォレエート、 POEグリセリンジステアレート等の POEグリセリン脂肪 酸エステル類、 POEモノォレエート、 POEジステアレート、 POEモノジォレエート等 の POE脂肪酸エステル類、 POEラウリルエーテル、 POEォレイルエーテル、 POEコ レスタノールエステル等の POEアルキルエーテル類、 POEォクチルフエニルエーテ ノレ、 POEノユルフェニルエーテル等の POEアルキルフエニルエーテル類、プルロニ ック等のプルァロニック型類、 POE · POPモノブチルエーテル POE · POPアルキルェ 一テル類、 POEヒマシ油、 POE硬化ヒマシ油、 POE硬化ヒマシ油モノイソステアレー ト、 POE硬化ヒマシ油マレイン酸等の POEヒマシ油硬化ヒマシ油誘導体、 POEソル ビットミツロウ等の POEミツロウ'ラノリン誘導体、ヤシ油脂肪酸ジエタノールアミド、脂 肪酸イソプロパノールアミド等のアル力ノールアミド、 POEプロピレングリコール脂肪 酸エステル、 POE脂肪酸アミド、 POEァノレキノレアミン、ショ糖脂肪酸エステル、アルキ ルエトキシジメチルアミンォキシド等の親水性非イオン界面活性剤等が挙げられる。 Surfactants include soap bases, fatty acid soaps such as sodium laurate and sodium normitate, higher alkyl sulfates such as sodium lauryl sulfate and potassium lauryl sulfate, POE lauryl sulfate triethanolamine, POE ralyl sulfate sodium, etc. Alkyl ether sulfate ester salt, N-acyl sarcosine acid such as lauroyl sarcosine sodium, N-myristoyl N-methyl taurine sodium, coconut oil fatty acid methyl tauride sodium and other higher fatty acid amide sulfonic acid, POE stearyl ether phosphorus Phosphate esters such as acids, monolauroyl monoethanolamide, sulfosuccinates such as sodium POE sulfosuccinate, sodium lauryl polypropylene glycol sulfosuccinate, linear dodecylbenzenes Alkylbenzene sulfonates such as sodium phonate, linear dodecylbenzene sulfonate triethanolamine, N-acyl glutamate such as N-stearoyl glutamate monosodium, N-stearoyl glutamate monosodium, hydrogenated coconut oil fatty acid sodium glycerine sulfate, etc. Higher fatty acid ester sulfate ester salt, sulfated oil such as funnel oil, POE alkyl ether carboxylic acid, POE alkyl aryl ether carboxylate, higher fatty acid ester sulfonate, secondary alcohol sulfate ester salt, higher fatty acid alkylol Anionic surfactants such as amidosulfuric acid ester salt, sodium lauroyl monoethanolamide succinate, sodium caseinate; Alkyltrimethylammonium salts such as tearyltrimethylammonium, lauryltrimethylammonium chloride, dialkyldimethylammonium salts such as distearyldimethylammonium chloride, alkylpyridinium salts such as cetylpyridinium chloride, Alkyl quaternary ammonium salts, alkyl dimethyl methyl benzyl ammonium salts, alkyl isoquinoline salts, dialkyl morphonium salts, POE anolequinoleamines, anolequinoleamine salts, polyamine fatty acid derivatives, amyl alcohol Fatty acid derivatives, powers such as benzalkonium chloride, thione surfactants; 2-cocoyl 2-imidazolinium hydroxydo 1 carboxylic acid imidazoline amphoteric surfactants such as shetiloxini sodium salt, amide betaine, sulfobetaine, etc. Betaine world Amphoteric surfactants such as surfactants; sorbitan monooleate, sorbitan monoisostearate, sorbitan monolaurate, sorbitan monopalmitate, sorbitan fatty acid esters such as sorbitan trioleate, mono cottonseed oil fatty acid glycerin, Glyceryl monostearate, glyceryl sesquioleate, glycerin polyglycerin fatty acids such as monostearic acid glycerin malate, propylene glycol fatty acid esters such as propylene glycol monostearate, hardened castor oil derivative, darisylene alkyl ether, ΡΟΕ Lipophilic nonionic surfactant such as methylpolysiloxane copolymer; POE sorbitan fatty acid esters such as POE sorbitan monooleate, POE sorbitan monostearate, POE sorbit monolaurate POE sorbite fatty acid esters such as POE sorbite monooleate, POE sorbite monostearate, etc. POE fatty acid esters, POE lauryl ether, POE oleyl ether, POE alkyl ethers such as POE cholesterol ester, POE alkyl phenyl ethers such as POE octyl phenyl ether, POE alkyl phenyl ethers, pluroni POE, POP monobutyl ether, POE, POP alkyl ether, POE castor oil, POE hydrogenated castor oil, POE hydrogenated castor oil monoisostearate, POE hydrogenated castor oil maleic acid, etc. Oil-hardened castor oil derivative POE beeswax 'lanolin derivatives such as POE sorbite beeswax, coconut oil fatty acid diethanolamide, alanol amides such as fatty acid isopropanolamide, POE propylene glycol fat Examples thereof include hydrophilic nonionic surfactants such as acid esters, POE fatty acid amides, POE anolenoleamines, sucrose fatty acid esters, and alkylethoxydimethylamine oxides.
[0024] アルコール類としては、メタノーノレ、エタノール、プロパノール、イソプロパノール等 の低級アルコール、シトステロール、ラノステロール等が挙げられる。  [0024] Examples of alcohols include methanol, lower alcohols such as ethanol, propanol, and isopropanol, sitosterol, and lanosterol.
[0025] 増粘剤としては、アラビアゴム、トラガントガム、ガラクタン、キヤロブガム、グァーガム 、カラギーナン、ぺクチン、寒天、デンプン(トウモロコシ、コムギ、ジャガイモ、コメ)等 の植物系高分子、デキストラン、プルラン等の微生物系高分子、カルボキシメチルデ ンプン、メチルヒドロキシプロピルデンプン等のデンプン系高分子、コラーゲン、カゼ イン、ゼラチン等の動物系高分子、メチノレセノレロース、ニトロセノレロース、ェチノレセノレ ロース、ヒドロキシェチノレセノレロース、セノレロース 酸ナトリウム、ヒドロキシプロピノレセ ノレロース、カノレポキシメチノレセノレロース、結晶セノレロース等のセノレロース系高分子、 アルギン酸ナトリウム、アルギン酸プロピレングリコールエステル等のアルギン酸系高 分子、ポリビュルメチルエーテル、カルボキシビュルポリマー等のビュル系高分子、 P OE系高分子、 POE'POP共重合体系高分子、ポリアクリル酸ナトリウム、ポリアクリノレ 酸アミド等のアクリル系高分子、ポリエチレンィミン、カチオンポリマー、ベントナイト、 ケィ酸アルミニウムマグネシウム、ラボナイト、ヘクトライト、無水ケィ酸等の無機系水 溶性高分子等の水溶性高分子等が挙げられる。  [0025] Thickeners include plant gums such as gum arabic, tragacanth gum, galactan, ginger gum, guar gum, carrageenan, pectin, agar, starch (corn, wheat, potato, rice), microorganisms such as dextran, pullulan, etc. Polymers, carboxymethyl starch, starch polymers such as methylhydroxypropyl starch, animal polymers such as collagen, casein, gelatin, methinoresenorelose, nitrosenorelose, ethinoresenorose, hydroxyethinoresenore Cholesterol polymers such as loin, sodium cenorelose, hydroxypropenoresenololose, canolepoxy methinorescenellose, crystalline cenorelose, algin such as sodium alginate, propylene glycol ester of alginate High molecular weight polymers, polybutyl methyl ether, bulbu polymers such as carboxybulu polymers, POE polymers, POE'POP copolymer polymers, acrylic polymers such as sodium polyacrylate and polyacryloamide, polyethylene And water-soluble polymers such as inorganic water-soluble polymers such as imine, cationic polymer, bentonite, magnesium aluminum kainate, labonite, hectorite, and anhydrous caustic acid.
[0026] キレート剤としては、シトラマル酸、ァガル酸、グリセリン酸、シキミ酸、ヒノキチォー ル、没食子酸、タンニン酸、コーヒー酸、エチレンジァミン四酢酸、エチレングリコール ジァミン四酢酸、ジエチレントリアミン五酢酸、フィチン酸、ポリリン酸、メタリン酸、なら びにこれらの類似体ならびにこれらのアルカリ金属塩およびカルボン酸エステル等が 挙げられる。  [0026] Examples of the chelating agent include citramalic acid, fagaric acid, glyceric acid, shikimic acid, hinokitiol, gallic acid, tannic acid, caffeic acid, ethylenediammine tetraacetic acid, ethylene glycol diaminetetraacetic acid, diethylenetriaminepentaacetic acid, phytic acid, polyphosphorus Examples thereof include acids, metaphosphoric acids, analogs thereof, and alkali metal salts and carboxylic acid esters thereof.
[0027] 活性酸素消去剤としては、スーパーォキシドデイスムターゼ、マンニトール、力タラ ーゼ、 β—カロチン、バイカリン、ノ イカレイン、ハイドロキノン誘導体、ビリノレリン、コレ ステローノレ、トリプトファン、ヒスチジン、タエルセチン、クエルシトリン、カテキン、カテ キン誘導体、没食子酸、没食子酸誘導体、 2— Ο—ェチルァスコルビン酸、プロアン トシァニジン、セサミン、ェピセサミン、メリッサ抽出物、ェンメイソゥ抽出物、セージ抽 出物、ローズマリー抽出物、エレウテ口コック抽出物、イチヨウ抽出物、チヨウジ抽出物 、クジン抽出物、ハマメリス抽出物、ソゥハクヒ抽出物、バジル抽出物、ォタネニンジン 抽出物、トウキ抽出物、ォゥゴン抽出物、センキユウ抽出物等が挙げられる。 [0027] As the active oxygen scavenger, superoxide dismutase, mannitol, force tarase, β-carotene, baicalin, neucarlein, hydroquinone derivative, vinorelin, cholesterol, tryptophan, histidine, taercetin, quercitrin, catechin , Catechin derivative, gallic acid, gallic acid derivative, 2 -—- ethylscorbic acid, proanthocyanidin, sesamin, epicesamine, Melissa extract, Enmeiso extract, sage extract, rosemary extract, Eloute mouth Kok extract, yew extract, jyoji extract , Kujin extract, hamamelis extract, sohakuhi extract, basil extract, ginseng extract, toki extract, gongon extract, senki extract and the like.
[0028] 紫外線吸収剤としては、パラアミノ安息香酸等の安息香酸系紫外線吸収剤;アント ラニル酸メチル等のアントラニル酸系紫外線吸収剤;サリチル酸ォクチル等のサリチ ル酸系紫外線吸収剤;パラメトキシケィ皮酸イソプロピル、ノ ラメトキシケィ皮酸ォクチ ル等のケィ皮酸系紫外線吸収剤; 2、 4ージヒドロキシベンゾフエノン、 2 ヒドロキシ —4—メトキシベンゾフエノン等のベンゾフエノン系紫外線吸収剤;ゥロカニン酸、ゥロ 力ニン酸ェチル等が挙げられる。  [0028] Examples of the ultraviolet absorber include benzoic acid-based ultraviolet absorbers such as paraaminobenzoic acid; anthranilic acid-based ultraviolet absorbers such as methyl anthranilate; salicylic acid-based ultraviolet absorbers such as octyl salicylate; Key cinnamate UV absorbers such as isopropyl acid and normethoxy key cinnamate; benzophenone UV absorbers such as 2,4-dihydroxybenzophenone and 2-hydroxy-4-methoxybenzophenone; urocanic acid and urocanic acid For example, strong ethyl ninlate.
[0029] 保湿剤としては、ポリエチレングリコール、プロピレングリコール、ジプロピレングリコ ール、 1 , 3—ブチレングリコール、グリセリン、ジグリセリン、キシリトール、マルチトー ル、マルトース、 D—マンニット、ブドウ糖、果糖、コンドロイチン硫酸ナトリウム、ヒアル ロン酸ナトリウム、乳酸ナトリウム、ダルコサミン、シクロデキストリン等が挙げられる。  [0029] As the humectant, polyethylene glycol, propylene glycol, dipropylene glycol, 1,3-butylene glycol, glycerin, diglycerin, xylitol, maltitol, maltose, D-mannitol, glucose, fructose, chondroitin sulfate Examples include sodium, sodium hyaluronate, sodium lactate, darcosamine, cyclodextrin and the like.
[0030] 薬効成分としては、ビタミン A油、レチノール、ノ ルミチン酸レチノール、塩酸ピリド キシン、ニコチン酸ベンジル、ニコチン酸アミド、ニコチン酸 dl— a—トコフエノール、 ァスコルビン酸リン酸マグネシウム、ビタミン D2、 dl— α -トコフエロール、パントテン酸 、ビォチン等のビタミン類;ァズレン、グリチルリチン等の抗炎症剤;アルブチン等の美 白剤、エストラジオール等のホルモン剤;酸化亜鉛、タンニン酸等の収斂剤; Lーメン トール、カンフル等の清涼剤;その他塩化リゾチーム、塩酸ピリドキシン、ィォゥ等を配 合すること力 Sできる。さらに多様な薬効を示す各種抽出物を配合することができる。す なわちドクダミエキス、ォゥバタエキス、カンゾゥエキス、シャクャクエキス、ボタンピエ キス、へチマエキス、ユキノシタエキス、ユーカリエキス、チヨウジエキス、マロニエェキ ス、ャグルマギクエキス、海藻エキス、タイムエキス等が挙げられる。  [0030] Medicinal ingredients include vitamin A oil, retinol, retinol normitate, pyridoxine hydrochloride, benzyl nicotinate, nicotinamide, nicotinic acid dl—a-tocophenol, magnesium ascorbate phosphate, vitamin D2, dl — Vitamins such as α-tocopherol, pantothenic acid, biotin; anti-inflammatory agents such as azulene and glycyrrhizin; whitening agents such as arbutin; hormonal agents such as estradiol; astringents such as zinc oxide and tannic acid; L-menthol, It is possible to combine a refreshing agent such as camphor; other lysozyme chloride, pyridoxine hydrochloride, io, etc. Furthermore, various extracts showing various medicinal effects can be blended. In other words, there are Dokudami extract, Aubata extract, Kanzo extract, Peonies extract, Button pie kiss, Hechima extract, Yukinoshita extract, Eucalyptus extract, Chii-jiji extract, Maroniex, cornflower extract, seaweed extract, thyme extract and the like.
[0031] 防腐剤としては、メチルパラベン、ェチルパラベン、ブチルパラベン等のパラォキシ 安息香酸エステル類、安息香酸、サリチル酸、ソルビン酸、パラクロルメタタレゾール 、へキサクロ口フェン、塩化ベンザルコニゥム、塩化クロルへキシジン、トリクロロカノレノ 二リド、感光素、フエノキシエタノール等が挙げられる。  [0031] As preservatives, paraoxybenzoates such as methylparaben, ethylparaben, and butylparaben, benzoic acid, salicylic acid, sorbic acid, parachlormetatalesol, hexacloguchiphene, benzalkonium chloride, chlorhexidine chloride, trichloro Canolenolide, photosensitizer, phenoxyethanol and the like.
[0032] 中和剤としては、 2—アミノー 2—メチルー 1 プロパノール、 2—アミノー 2—メチル [0032] As neutralizing agents, 2-amino-2-methyl-1-propanol, 2-amino-2-methyl
1、 3—プロパンジオール、水酸化カリウム、水酸化カリウム、トリエタノールァミン、 炭酸ナトリウム等が挙げられる。 1,3-propanediol, potassium hydroxide, potassium hydroxide, triethanolamine, Sodium carbonate etc. are mentioned.
[0033] pH調整剤としては、乳酸、クェン酸、グリコール酸、コハク酸、酒石酸、リンゴ酸、炭 酸水素ナトリウム、炭酸水素アンモユウム等が挙げられる。 [0033] Examples of the pH adjuster include lactic acid, citrate, glycolic acid, succinic acid, tartaric acid, malic acid, sodium hydrogen carbonate, ammonium hydrogen carbonate and the like.
[0034] 酸化防止剤としては、ァスコルビン酸、 α—トコフエロール、カロチノイド等が挙げら れる。 [0034] Examples of the antioxidant include ascorbic acid, α-tocopherol, carotenoid and the like.
[0035] 上記成分は例示であり、これらに限定されるものではない。またこれら成分は、所望 する形態に応じた処方に従い、適宜組み合わせて配合することが可能である。  [0035] The above-described components are illustrative and are not limited thereto. Further, these components can be appropriately combined and blended according to a prescription according to a desired form.
[0036] また、本発明の皮膚外用剤は、外皮に適用される化粧料、医薬品、医薬部外品等 、特に好適には化粧料に広く適用することが可能であり、その剤型も、皮膚に適用で きるものであればいずれでもよぐ溶液系、可溶化系、乳化系、粉末分散系、水-油 二層系、水-油-粉末三層系、軟膏、ゲル、エアゾール等、任意の剤型が適用される [0036] Further, the external preparation for skin of the present invention can be widely applied to cosmetics, pharmaceuticals, quasi-drugs and the like applied to the outer skin, and particularly preferably to cosmetics. Any solution system, solubilization system, emulsification system, powder dispersion system, water-oil two-layer system, water-oil-powder three-layer system, ointment, gel, aerosol, etc. Any dosage form is applied
Yes
[0037] また、本発明の皮膚外用剤の使用形態も任意であり、例えば化粧水、乳液、タリー ム、パック等のフエ一シャル化粧料やファンデーションの他、メーキャップ化粧料、芳 香化粧料、浴用剤等に用いることができる。なお、上記の剤型および使用形態に本 発明の皮膚外用剤がとり得る形態が限定されるものではない。  [0037] Further, the form of use of the external preparation for skin of the present invention is also arbitrary. For example, in addition to facial cosmetics and foundations such as lotions, emulsions, tames, packs, makeup cosmetics, aromatic cosmetics, It can be used for bathing agents. In addition, the form which the skin external preparation of this invention can take is not limited to said dosage form and usage form.
[0038] 本発明の薬剤を配合した皮膚外用剤は、医薬品、医薬部外品(軟膏剤、歯磨剤等 )及び化粧品、例えば洗顔料、乳液、クリーム、ジエル、エッセンス(美容液)、パック、 マスク等の基礎化粧品;ファンデーション、口紅等のメーキャップ化粧品;口腔化粧品 、芳香化粧品、毛髪化粧品、ボディ化粧品等の形態に広く適用可能である。なお、こ れらの形態に、上記皮膚外用剤の取り得る形態が限定されるものではない。  [0038] The topical skin preparation containing the agent of the present invention includes pharmaceuticals, quasi-drugs (ointments, dentifrices, etc.) and cosmetics such as facial cleansers, emulsions, creams, jewels, essences (beauty liquids), packs, It can be widely applied to basic cosmetics such as masks; makeup cosmetics such as foundations and lipsticks; oral cosmetics, aromatic cosmetics, hair cosmetics, body cosmetics and the like. In addition, the form which the said skin external preparation can take is not limited to these forms.
[0039] また、剤型も水溶液系、可溶化系、油液系、ゲル系、軟膏系、エアゾール系、水 油 2層系、水 油 粉末 3層系等、幅広い剤型を取り得る。  [0039] In addition, the dosage form can be a wide range of dosage forms such as an aqueous solution system, a solubilization system, an oil liquid system, a gel system, an ointment system, an aerosol system, a water oil two layer system, and a water oil powder three layer system.
[0040] 本発明の抗しわ剤を配合した皮膚外用剤を使用することにより、しわ、特に小じわを 防止 ·改善し、若々しくみずみずし!/、肌を提供することが可能である。  [0040] By using the external preparation for skin containing the anti-wrinkle agent of the present invention, it is possible to prevent and improve wrinkles, particularly fine wrinkles, and to provide youthful and fresh skin!
実施例  Example
[0041] 次に実施例を挙げ、本発明をさらに詳細に説明する。本発明はこれにより限定され るものではない。ここで、配合量は質量%である。実施例に先立ち、本発明のしわ防 止 ·改善剤の効果試験につ!/、て述べる。 [0041] Next, the present invention will be described in more detail with reference to examples. The present invention is not limited thereby. Here, a compounding quantity is the mass%. Prior to Examples, the wrinkle prevention of the present invention Demonstrate the effectiveness of the improving agent!
[0042] A.植物抽出物の調製 [0042] A. Preparation of plant extract
以下の植物は!/、ずれもネパール産の植物を用いた。  The following plants were used from Nepal!
(l) Elaeocarpus sphaericusの 50%エタノーノレ水溶液抽出物  (l) 50% ethanol aqueous extract of Elaeocarpus sphaericus
Elaeocarpus sphaericusの果実 10· Ogを、室温で 1週間 150mlの 50%エタノール 水溶液に浸漬し、抽出液をろ過、溶媒を留去し、 50%エタノール水溶液抽出物 3. 3 gを得た。  Elaeocarpus sphaericus fruit 10 · Og was immersed in 150 ml of 50% aqueous ethanol at room temperature for 1 week, the extract was filtered and the solvent was distilled off to obtain 3.3 g of 50% aqueous ethanol extract.
[0043] (2) Quercus lineata Blume.のメタノール抽出物  [0043] (2) Quercus lineata Blume. Methanol extract
Quercus lineata Blume.の樹皮 50· 3gを、室温で 1週間 500mlのメタノールに浸漬 し、抽出液をろ過、溶媒を留去し、メタノール抽出物 6. 55gを得た。  Quercus lineata Blume. Bark 50 · 3 g was immersed in 500 ml of methanol for 1 week at room temperature, the extract was filtered and the solvent was distilled off to obtain 6.55 g of methanol extract.
[0044] (3) Quercus lanata Sm.の 70%エタノール水溶液抽出物 [0044] (3) 70% ethanol aqueous extract of Quercus lanata Sm.
Quercus lanata Sm.の種子 10· 2gを、室温で 1週間 100mlの 70%エタノール水溶 液に浸漬し、抽出液をろ過、溶媒を留去し、 70%エタノール水溶液抽出物 6. 3gを 得た。  Quercus lanata Sm. Seeds (10-2 g) were immersed in 100 ml of 70% aqueous ethanol at room temperature for 1 week, the extract was filtered and the solvent was distilled off to obtain 6.3 g of 70% aqueous ethanol extract.
[0045] (4) Pinus wallichiana A.B.Jacks のエタノール抽出物  [0045] (4) Ethanol extract of Pinus wallichiana A.B.Jacks
Pinus wallichiana A.B.Jacksの樹皮 51. lgを、室温で 1週間 500mlのエタノールに 浸漬し、抽出液をろ過、溶媒を留去し、エタノール抽出物 10. 4gを得た。  51. lg of Pinus wallichiana A.B. Jacks bark was soaked in 500 ml of ethanol for 1 week at room temperature, the extract was filtered and the solvent was distilled off to obtain 10.4 g of ethanol extract.
[0046] (5) Dioscorea esculenta Burkillの 80%エタノール水溶液抽出物 [0046] (5) 80% aqueous ethanol extract of Dioscorea esculenta Burkill
Dioscorea esculenta Burkillの球根 10gを、室温で 1週間 100mlの 80%エタノール 水溶液に浸漬し、抽出液をろ過、溶媒を留去し、 80%エタノール水溶液抽出物 1. 1 gを得た。  Dioscorea esculenta Burkill bulb (10 g) was immersed in 100 ml of 80% ethanol aqueous solution for 1 week at room temperature, the extract was filtered and the solvent was distilled off to obtain 1.1 g of 80% ethanol aqueous extract.
[0047] (6) Cochlospermum religiosum (し) Alstonのエタノール由出物  [0047] (6) Cochlospermum religiosum
Cochlospermum religiosum (し) Alstonの樹皮 10. 0gを、室温で 1週間 100mlのェ タノールに浸漬し、抽出液をろ過、溶媒を留去し、エタノール抽出物 0. 84gを得た。  Cochlospermum religiosum (Nishi) Alston bark (10.0 g) was immersed in 100 ml of ethanol for 1 week at room temperature, the extract was filtered and the solvent was distilled off to obtain 0.84 g of ethanol extract.
[0048] (7) Coriaria nepalensis Wall. (7)50% 1 , 3—ブチレングリコール水溶液抽出物 [0048] (7) Coriaria nepalensis Wall. (7) 50% 1,3-butylene glycol aqueous solution extract
Coriaria nepalensis Wall.の全草 10. 2gを、室温で 1週間 150mlの 50% 1 , 3—ブ チレングリコール水溶液に浸漬し、抽出液をろ過、溶媒を留去し、 50% 1 , 3ブチレン グリコール水溶液抽出物: L 72gを得た。 [0049] (8) Cinnamomum bejolghota (7)30% 1 , 3—ブチレングリコール水溶液抽出物 Coriaria nepalensis Wall. 10.2 g whole plant is immersed in 150 ml of 50% 1,3-butylene glycol aqueous solution at room temperature for 1 week, filtered, the solvent is distilled off, 50% 1,3 butylene glycol Aqueous extract: L 72 g was obtained. [0049] (8) Cinnamomum bejolghota (7) 30% 1,3-butylene glycol aqueous solution extract
Cinnamomum bejolghotaの樹皮 10. 9gを、室温で 1週間 150mlの 30% 1 , 3—ブ チレングリコール水溶液に浸漬し、抽出液をろ過、溶媒を留去し、 30% 1 , 3—ブチレ ングリコール水溶液抽出物 1. 23gを得た。  Cinnamomum bejolghota bark 10.9 g is immersed in 150 ml of 30% 1,3-butylene glycol aqueous solution for 1 week at room temperature, the extract is filtered, the solvent is distilled off, 30% 1, 3-butylene glycol aqueous solution Extract 1.23 g was obtained.
[0050] B. ADAM活性阻害物質のスクリーニング  [0050] B. Screening for ADAM activity inhibitors
まず、 HB-EGF-AP/HT-1080 (ヒト HB-EGFの N末端に耐熱性アルカリフォスファタ ーゼ (AP)を付加した融合蛋白質を強制的に発現するように改変したヒト線維肉腫由 来培養細胞 HT-1080)を用いて ADAM酵素阻害活性を有する化合物のスクリー二 ングを行つた。用レ、た細胞株 HB-EGF-AP/HT- 1080の細胞表面上にはアル力リフ ォスファターゼと融合した形で HB-EGF全長分子が発現して!/、る。この細胞をホルボ ールエステルで刺激すると、細胞膜表面上の ADAM酵素が活性化されて HB-EGF 分子を切断する。切断されて遊離型となった HB-EGFにはアルカリフォスファターゼ が結合しているため、培養上清中のアルカリフォスファターゼ活性を測定することで 化合物の ADAM酵素阻害活性を間接的に測定できる。  First, HB-EGF-AP / HT-1080 (derived from human fibrosarcoma modified to forcibly express a fusion protein with the addition of thermostable alkaline phosphatase (AP) to the N-terminus of human HB-EGF) The cultured cells (HT-1080) were used to screen for compounds having ADAM enzyme inhibitory activity. The full-length HB-EGF molecule is expressed on the cell surface of the cell line HB-EGF-AP / HT-1080 in the form fused with alfa phosphatase! /. When these cells are stimulated with phorbol esters, ADAM enzymes on the cell membrane surface are activated and cleave HB-EGF molecules. Since cleaved free HB-EGF is bound with alkaline phosphatase, the ADAM enzyme inhibitory activity of the compound can be indirectly measured by measuring the alkaline phosphatase activity in the culture supernatant.
[0051] 具体的には、 2.0xl05cells/mlになるように細胞数を調整した HB-EGF-AP/HT-10 80を 96ゥエル培養用マイクロプレートに 0.2ml/wellずつ播種し、 37°Cでー晚培養した 。培地を除去し PBS (—)で洗浄後、被験物質を含む培地を 0. 1 ml/wellずつ添カロし、 37°Cで 30分間インキュベートして前処置した。その後、培養上清を除去し、再度被 験物質と 60nM TPA (ホルボールエステル: 12-o-Tetradecanoylphorbo卜 acetate; Sig ma P8139)を含む培地を 0. 2ml/wellずつ添加し、さらに 60分間インキュベートして処 置した。各被検物質の最終濃度は 10 g/mlおよび 5011 g/mlの両方で試験した[0051] Specifically, seeded by 0.2 ml / well of HB-EGF-AP / HT- 10 80 adjusted for cell number to be 2.0xl0 5 cells / ml in microplates for 96 Ueru culture, 37 Cultivation was carried out at ° C. After removing the medium and washing with PBS (—), the medium containing the test substance was supplemented with 0.1 ml / well and pretreated by incubation at 37 ° C. for 30 minutes. Thereafter, the culture supernatant is removed, and 0.2 ml / well of a medium containing the test substance and 60 nM TPA (phorbol ester: 12-o-Tetradecanoylphorbo 卜 acetate; Sigma P8139) is added again, and further incubated for 60 minutes. I was treated. The final concentration of each test substance was tested at both 10 g / ml and 5011 g / ml
Yes
[0052] 処置終了後の各ゥエルの培養上清 0. 1mlをアルカリフォスターゼ活性測定用マイク 口プレートのゥエルに移し、 65°Cにて 10分間インキュベートし、内在性のアルカリフォ スターゼを失活させた。 lmg/mlの AP基質(p-nitrophenylphosphate, Wako; 141-023 41)を 0. lml/wellずつ各ゥエルに添加し、直ちに各ゥエルの 405nmでの吸光度を測 定した。遮光して室温にて 2時間インキュベートしたのち、再び各ゥエルの 405nmで の吸光度を測定した。 2時間インキュベート後の吸光度から AP基質添加直後の吸光 度を減じたものを各ゥエルの吸光度とした。 0%阻害コントロール (TPAのみを含む培 地)の吸光度を A0、 100%阻害コントロール(培地のみ)の吸光度を A100、試料の吸 光度を ASとし、以下の式により阻害率(%)を算出した。 [0052] After completion of the treatment, 0.1 ml of the culture supernatant of each well was transferred to the well of the microphone plate for alkaline phosphatase activity measurement and incubated at 65 ° C for 10 minutes to inactivate endogenous alkaline phosphatase. I let you. lmg / ml AP substrate (p-nitrophenylphosphate, Wako; 141-023 41) was added to each well 0.1 ml / well, and the absorbance of each well was measured immediately at 405 nm. After incubation for 2 hours at room temperature in the dark, the absorbance of each well at 405 nm was measured again. Absorbance immediately after addition of AP substrate from absorbance after 2 hours incubation The absorbance of each well was obtained by subtracting the degree. The absorbance of the 0% inhibition control (medium containing only TPA) is A0, the absorbance of the 100% inhibition control (medium only) is A100, and the absorbance of the sample is AS. .
[0053] 阻害率(%) = (八0—八5) / (八0—八100) 100 [0053] Inhibition rate (%) = (80-8) / (80-8) 100
[0054] その結果を表 1に示す。表 1力、ら、ホルトノキ科の Elaeocarpus sphaericus,ブナ科の Quercus lineata Blume.、プナ禾斗の Quercus lanata Sm.、マツ科の Pinus wallichiana A. B.Jacks、ャマノィモ禾斗の Dioscorea esculenta Burkill、ヮタリモドキ禾斗の Cochlospermu m religiosum (し) Alston、ドクゥツ 禾斗の Coriaria nepalensis Wall. クスノキ禾斗の Cinna momum bejolghotaに高い HB— EGF遊離抑制効果が認められ、 ADAM活性を阻害 することが示唆された。  The results are shown in Table 1. Table 1 Power, et al, Elaeocarpus sphaericus from the family Alasciaceae, Quercus lineata Blume. From the beech family, Quercus lanata Sm. From the pine family, Pinus wallichiana ABJacks from the pine family, Dioscorea esculenta Burkill from the pine family, Cochlosper muco m religiosum (Shi) Alston, Coriaria nepalensis Wall of Dokutsu Toshi Cinna momum bejolghota has a high inhibitory effect on HB—EGF release, suggesting that it inhibits ADAM activity.
[0055] [表 1]  [0055] [Table 1]
Figure imgf000016_0001
Figure imgf000016_0001
[0056] C.しわ改善剤の効果試験 (バリア破壊しわモデルを用いた小じわ改善効果測定方 法)  [0056] C. Effect test of wrinkle improving agent (Measurement method of fine wrinkle improvement effect using barrier destruction wrinkle model)
ヘアレスマウス(HR— 1、雄 6週齢、星野実験動物)の左側背部に TEWL (水分蒸 散測定装置 Meeco(Meeco, USA)を用いて測定)が 7〜; !Omgん m2/hになるように調整 しながらテープストリツビングを週 3回、 4週間継続して行い、毎回テープストリツビング 処置直後に 1 % Cochlospermum religiosum (し) Alston/エタノーノレ液又は 1 % Que reus lanata Sm./70%エタノール水溶液を 100 1ずつ塗布した。 n数は 6から 7とし た。 TEWL (measured using a water transpiration measuring device Meeco (Meeco, USA)) on the left back of a hairless mouse (HR-1, male 6 week old, Hoshino experimental animal) 7 ~; Omg / m 2 / h Tape stripping 3 times a week for 4 weeks while adjusting to 1% Cochlospermum religiosum (1) Alston / ethanolol solution or 1% Que reus lanata Sm./ A 100% 70% aqueous ethanol solution was applied one by one. The n number was 6-7.
[0057] 4週間後のしわの発生状況を 4名の判定者が肉眼観察によりスコア化した。しわの 発生状況は「しわなし; 0」、「うすいしわ; 1」、「明らかなしわ; 2」、「深いしわ; 3」とし、 0[0057] The occurrence of wrinkles after 4 weeks was scored by four examiners by visual observation. Wrinkled Occurrence status is “no wrinkles; 0”, “light wrinkles; 1”, “obvious wrinkles; 2”, “deep wrinkles; 3”, 0
. 5刻みで点数化した。評点が大きいほどしわが深いことを示す。各群の平均値およ び標準偏差を算出して薬剤の効果を図 1に示した。 . Scored in 5 increments. The larger the score, the deeper the wrinkle. The mean and standard deviation of each group was calculated and the effect of the drug is shown in Fig. 1.
[0058] 図 1中、「Vehicle」は薬剤なし(エタノール液または 70%エタノール水溶液)を示す。 In FIG. 1, “Vehicle” indicates no drug (ethanol solution or 70% ethanol aqueous solution).
図 1より、 Cochlospermum religiosum (し) Alston^ Quercus lanata Sm.は、 Vehicleと比 較して有意にしわ抑制効果を示すことがわかる。  Figure 1 shows that Cochlospermum religiosum Alston ^ Quercus lanata Sm. Has a significant wrinkle suppression effect compared to Vehicle.
[0059] 同時に経表皮水分蒸散量(Trans印 idermal Water Loss; TEWL) ^Vapometer (Del fm,フィンランド)を用いて測定した。 TEWLは肌荒れの指標で、数値が高いほど肌状 態が悪化していることを示す。同一個体の右側背部(=テープストリツビングを行って[0059] Simultaneously, transepidermal water transpiration (Trans mark idermal Water Loss; TEWL) was measured using a ^ Vapometer (Del fm, Finland). TEWL is an index of rough skin. The higher the value, the worse the skin condition. The right back of the same individual (= tape stripping
V、な!/、部位)の TEWL値(NT)に対する左側背部(=テープストリツビングを行って!/ヽ る部位)の TEWL値 (TS)の比を求め、各群の平均値および標準偏差を算出した。 その結果を図 2に示す。 The ratio of the TEWL value (TS) of the left dorsal part (= tape stripping! / The part where the tape is stripped) to the TEWL value (NT) of V, NA! Deviation was calculated. The result is shown in Fig.2.
図 2に示す通り、 Vehicle塗布群では TEWLが約 1. 5倍に上昇した力 S、 1 % Cochlos permum religiosum (Lj Alston/エタノーノレ Ϊ仪又は 1 % Quercus lanata Sm./ ί0% エタノール水溶液を塗布した群ではテープストリツビングにより惹起される TEWLの 上昇を有意に抑制することが明らかとなった。  As shown in Fig. 2, in the vehicle application group, TEWL was increased by about 1.5 times the force S, 1% Cochlos permum religiosum (Lj Alston / Ethananol or 1% Quercus lanata Sm./ ί0% ethanol aqueous solution was applied. In the group, it was found that the TEWL increase caused by tape stripping was significantly suppressed.
[0060] これらの結果力、ら Cochlospermum religiosum (し) Alston、 Quercus lanata Sm.は AD[0060] These resulting forces, et al. Cochlospermum religiosum Alston, Quercus lanata Sm. AD
AM酵素活性を阻害し、肌荒れに伴う表皮肥厚を抑制することにより小じわ形成を防 止することが明らかになった。 It was revealed that fine wrinkle formation was prevented by inhibiting AM enzyme activity and suppressing epidermal thickening associated with rough skin.
[0061] 以下に本発明に係る抗しわ剤を用いた皮膚外用剤の処方例 (製剤例)を示す。な お、 V、ずれの皮膚外用剤も優れたしわ防止 ·改善効果を有して!/、た。 [0061] Formulation examples (formulation examples) of external preparations for skin using the anti-wrinkle agent according to the present invention are shown below. In addition, skin preparations for V and misalignment have excellent wrinkle prevention and improvement effects!
[0062] 製剤例 1 :しわ防止'改善用クリーム [0062] Formulation Example 1: Wrinkle prevention 'improvement cream
成分 配合量 (質量%)  Ingredient Compounding amount (mass%)
流動パラフィン 8  Liquid paraffin 8
ワセリン 3  Vaseline 3
ジメチノレポリシロキサン 2  Dimethinorepolysiloxane 2
ステアリノレアノレコーノレ 3  Stearino Reano Recone 3
ベへ: ^ノレァノレコーノレ 2 5 To: ^ Noreano Reconole 2 Five
ジプロピレングリコーノレ 4 Dipropylene glycol 4
トレノヽロース 1 Trueno porridge 1
テトラ 2—ェチルへキサン酸ペンタエリスリット 4 Tetra 2-ethylhexanoate pentaerythritol 4
ェ 2 ェ  2
親油型 2 Lipophilic mold 2
0. 05  0. 05
0. 05 水酸化カリウム 0. 015 Quercus lanata Sm.70%エタノール抽出液 2· 0 0. 05 Potassium hydroxide 0.015 Quercus lanata Sm. 70% ethanol extract 2.0
Elaeocarpus sphaericus50%エタノーノレ田出 ί夜 0. 001 酢酸トコフェローノレ 0. Elaeocarpus sphaericus 50% Etanore Taide ί 夜 0. 001 Tocopheronole acetate 0.
パラォキシ安息香酸 Paraoxybenzoic acid
フエノキシエタノーノレ Phenoxy ethanol
ェデト酸三ナトリウム 0. 05 4— tーブチルー 4, - 0. 01 パラメトキシ桂皮酸 2—ェチルへキシル 0. 1 β一力ロチン 0. 01 ポリビニノレアノレコーノレ 0. 5 Edetate trisodium 0.05-4-tert-butyl 4-,-0. 01 paramethoxycinnamic acid 2-ethyl hexyl 0. 1 β-strength rotin 0. 01 Polyvinylenorenoreconole 0.5
ース 0. 5 カノレポキシビニノレポリマー 0. 05 精製水  0.5 canolepoxivininopolymer 0.5.5 Purified water
香料 Fragrance
製剤例 2:しわ防止 ·改善用クリーム  Formulation Example 2: Wrinkle prevention · Cream for improvement
成分 配合量 (質量%) マー 10 ワセリン Ingredient Blending amount (mass%) Vaseline
3  Three
サン 5  Sun 5
10  Ten
2  2
2  2
、一ノレ 2 グリセリン脂肪酸エステルエイコサン二酸縮合物 0.  1 Norre 2 Glycerin fatty acid ester eicosane diacid condensate 0.
2ーェチノレへキサン酸セチノレ 5 2-etinorehexanoic acid cetinole 5
塩化ナトリウム 0. 5 Sodium chloride 0.5
へキサメタリン酸ナトリウム 0. 05 Sodium hexametaphosphate 0. 05
0. 05  0. 05
0. 1  0. 1
リン酸し 2 Phosphoric acid 2
酢酸トコフェローノレ 0. 5 Tocopherol acetate 0.5
Cinnamomum bejolghotadO% l , 3 コール抽出液 0 Quercus lineata Blume.エタノーノレ由出 ί夜 Cinnamomum bejolghotadO% l, 3 Cole extract 0 Quercus lineata Blume.
DL—ピロリドンカルボン酸ナトリウム DL—Sodium pyrrolidonecarboxylate
ェデト酸 3ナトリウム 0·
Figure imgf000019_0001
Edetic acid trisodium 0 ·
Figure imgf000019_0001
パラベン Paraben
精製水 purified water
香料 Fragrance
製剤例 3:しわ防止 ·改善用乳液 ワセリン 5 Formulation Example 3: Wrinkle prevention Vaseline 5
ベへ: T レアノレコ一ノレ 0. 5 To: T Reanoreco Nore 0. 5
コール 0. 5  Call 0.5
3—ブチレングリコール 7 3-Butylene glycol 7
2―ペンタンジ才ーノレ  2-Pentangi-Nore
3  Three
ポリエチレングリコーノレ 20000 2 Polyethylene glycolore 20000 2
硬化油 2 Hardened oil 2
ホホバ油 2 Jojoba oil 2
5  Five
0. 5  0.5
テトラ 2—ェチルへキサン酸ペンタエリスリット 2 Tetra 2-ethylhexanoic acid pentaerythritol 2
ポリオキシエチレン硬化ヒマシ油 0. 5 Polyoxyethylene hydrogenated castor oil 0.5
ラウリルジメチルァミノ酢酸べタイン 0. 4 Lauryldimethylaminoacetic acid betaine 0.4
水酸化カリウム 適量 Potassium hydroxide appropriate amount
ピロ亜硫酸ナトリウム 0. 01 Sodium pyrosulfite 0.01
へキサメタリン酸ナトリウム 0. 05 Sodium hexametaphosphate 0. 05
グリチルリチン酸ジカリウム 0. 05 Dipotassium glycyrrhizinate 0. 05
Dioscorea esculenta Burkill80%エタノーノレ抽出液 1. 0 Cochlospermum relgiousum (し) Alstonエタノーノレ由出 Ϊ仪 0. 05  Dioscorea esculenta Burkill 80% ethanol extract 1. 0 Cochlospermum relgiousum Yoshi Alston etenore タ 0. 05
3  Three
酵母エキス 0. 1 Yeast extract 0.1
酢酸トコフェローノレ 0. Tocopheronol acetate 0.
ベンガラ Bengala
クィンスシードエキス 0. Queen Seed Extract 0.
カノレポキシビニノレポリマー 0. 2 Canolepoxy bininole polymer 0.2
フエノキシエタノール 精製水 Phenoxyethanol purified water
製剤例 4:しわ防止 ·改善用乳液  Formulation Example 4: Wrinkle prevention
成分 配合量 (質量%) Ingredient Compounding amount (mass%)
-サン 15  -Sun 15
5  Five
ポリオキシエチレン'メチルポリシロキサン共重合体 5 Polyoxyethylene 'methylpolysiloxane copolymer 5
グリセリン 5 Glycerin 5
1 , 3—ブチレングリコーノレ 5 1, 3—Butyleneglycanol 5
マノレチトーノレ ί夜 2 Manoleto Tonore ί 夜 2
マカデミアナッツ油 2 Macadamia nut oil 2
2  2
酸コレステリノレ 0. 5 Acid Cholesterinore 0.5
2—ェチノレへキサン酸セチノレ 2 2-Ethinolehexanoic acid cetinole 2
Lーァスコルビン酸硫酸エステル 2ナトリウム 0. 1 L-ascorbic acid sulfate disodium 0.1
α -トコフエロール 2— L—ァスコルビン酸リン酸ジエステルカリウム 0. 酢酸トコフエロール 0. 05 α-Tocopherol 2-L-ascorbic acid potassium phosphate diester 0. Tocopherol acetate 0. 05
魚コラーゲン 0. 4 Fish collagen 0.4
コンドロイチン硫酸ナトリウム 0· 01 Sodium chondroitin sulfate 0 · 01
ヒアルロン酸ナトリウム 0. 1 Sodium hyaluronate 0.1
Coriaria nepalensis Wall.50% 1 , 3—ブチレングリコール抽出液 1. 0 Pinus wallichiana A. B. Jacksエタノーノレ由出 ί夜 1. 0  Coriaria nepalensis Wall. 50% 1, 3-Butylene glycol extract 1.0 Pinus wallichiana A. B. Jacks Ethanore Yuki ί 夜 1.0
ェデト酸三ナトリウム 0. 05 Edetate trisodium 0. 05
ジパラメトキシ桂皮酸モノー 2—ェチルへキサン酸グリセリル 0· 05 ケィ酸ァノレミニゥムマグネシウム 0· 3 Diparamethoxycinnamic acid mono-2-ethylglyceryl hexylate 0 · 05 Anoleminium magnesium kaylate 0 · 3
パラベン 適量 Paraben appropriate amount
精製水 purified water

Claims

請求の範囲 The scope of the claims
[1] ブナ科のクエルカス ラナタ エスエム. (学名: Quercus lanata Sm.)、ホルトノキ科 のェラオカルプス スファエリカス(学名: Elaeocarpus sphaericus)、ブナ科のタエルカ ス リネアタ ブルム. (学名: Quercus lineata Blume.)、マツ科のピヌス ゥオリチアナ エー.ビー.ジャタス(学名: Pinus wallichiana A.B.Jacks)、ャマノィモ科のディォス コレア エスクレンタ ブルキル(学名: Dioscorea esculenta Burkill)、ヮタリモドキ科の ココロスぺノレマム レリジォスム (エノレ. )ァノレストン (学名: Cochlospermum religiosum ( し) Alston)、ドクウツギ科のコリアリア ネパレンシス ウォール(学名: Coriaria nepale nsis Wall.)、クスノキ禾斗のシフ 'モマム ヘショノレコタ (' 名: Cinnamomum bejolghota 力、ら選ばれる一種または二種以上の植物、またはこれらの溶媒抽出物を含有するこ とを特徴とする抗しわ剤。  [1] Quercus lanata Sm. (Scientific name: Quercus lanata Sm.), Elaeocarpus sphaericus (scientific name: Elaeocarpus sphaericus), Taerukas lineata Blume. (Scientific name: Quercus lineata Blume.), Pine family Pinus wallichiana ABJacks (Scientific name: Pinus wallichiana ABJacks), Dioscorea esculenta Burkill (scientific name: Dioscorea esculenta Burkill) Alston), Coriania nepalensis wall (Scientific name: Coriaria nepale nsis Wall.), Schiff's shrimp 'Momamu Heshonorekota' (name: Cinnamomum bejolghota force, one or more plants selected from these, or these Containing a solvent extract of Anti-wrinkle agent characterized.
[2] ブナ科のタエノレカス ラナタ エスエム. (学名: Quercus lanata Sm.)、ブナ科のタエ ノレカス リネアタ ブルム. (学名: Quercus lineata Blume.)、マツ科のピヌス ゥオリチ アナ エー.ビー.ジャタス(学名: Pinus wallichiana A.B.Jacks)、ャマノィモ科のディ ォスコレア エスクレンタ ブルキル(学名: Dioscorea esculenta Burkill)、タスノキ科の シナモマム ベジョルゴタ(学名: Cinnamomum bejolghota)から選ばれる一種または 二種以上の植物、またはこれらの溶媒抽出物を配合してなることを特徴とする皮膚外 用剤。  [2] Taenolecus lanata Sm. Of the beech family (scientific name: Quercus lanata Sm.), Tae norecus linata blum of the beech family (scientific name: Quercus lineata Blume.), Pinus s. Pinus wallichiana ABJacks), Dioscorea esculenta Burkill (Scientific name: Dioscorea esculenta Burkill), Cinnamomum bejolggota (Scientific name: Cinnamomum bejolghota), or a solvent extract of these. A skin external preparation characterized by being formulated.
PCT/JP2007/069569 2006-10-10 2007-10-05 Anti-wrinkle agent and skin preparation for external use WO2008044636A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006276007A JP2008094734A (en) 2006-10-10 2006-10-10 Antiwrinkle agent and external preparation for skin
JP2006-276007 2006-10-10

Publications (1)

Publication Number Publication Date
WO2008044636A1 true WO2008044636A1 (en) 2008-04-17

Family

ID=39282832

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/069569 WO2008044636A1 (en) 2006-10-10 2007-10-05 Anti-wrinkle agent and skin preparation for external use

Country Status (2)

Country Link
JP (1) JP2008094734A (en)
WO (1) WO2008044636A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110403883A (en) * 2019-09-03 2019-11-05 杭州千岛湖蓝色天使实业有限公司 A kind of long anti-ageing smoothing toner of pubescence Chinese yam and preparation method thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2930557B1 (en) * 2008-04-29 2013-08-30 Lvmh Rech COLORING MATERIALS OF VEGETABLE ORIGIN AND THEIR USE FOR COLORING COMPOSITIONS, ESPECIALLY COSMETIC COMPOSITIONS
JP2010006708A (en) * 2008-06-24 2010-01-14 Shiseido Co Ltd External preparation for skin, bleaching agent, anti-aging agent and anti-oxidizing agent
JP2012056919A (en) * 2010-09-13 2012-03-22 Shiseido Co Ltd Hyaluronic acid production promotor

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006249018A (en) * 2005-03-11 2006-09-21 Suntory Ltd Antiaging agent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006249018A (en) * 2005-03-11 2006-09-21 Suntory Ltd Antiaging agent

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHHETRI D.R. ET AL.: "Antidiabetic plants used by Sikkim and Darjeeling Himalayan tribes", INDIA, JOURNAL OF ETHNOPHARMACOLGY, vol. 99, no. 2, 3 June 2005 (2005-06-03), pages 199 - 202, XP004891727 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110403883A (en) * 2019-09-03 2019-11-05 杭州千岛湖蓝色天使实业有限公司 A kind of long anti-ageing smoothing toner of pubescence Chinese yam and preparation method thereof

Also Published As

Publication number Publication date
JP2008094734A (en) 2008-04-24

Similar Documents

Publication Publication Date Title
JP3782779B2 (en) Topical skin preparation
EP1638991B1 (en) Cosmetic or dermopharmaceutical composition for reducing the signs of cutaneous ageing
US20080183250A1 (en) Compositions and methods for treating or preventing skin inflammation via restoration of skin barrier function
JP2007522161A (en) Cosmetic composition containing castanea sativa leaf extract
EP2897574A2 (en) Anti-dandruff composition comprising 1-acetoxychavicol acetate
JP7022700B2 (en) A composition for use in the treatment and / or prevention of juvenile acne vulgaris, which comprises a Harungana madagascariensis leaf extract, and a method for preparing the same.
WO2013146913A1 (en) Hdc activation inhibitor, hdc activation inhibition composition, antipruritic agent, and antipruritic agent composition
JPH027287B2 (en)
WO2011108304A1 (en) External preparation for skin
KR20090103992A (en) Use of gamma-amino butyric acid as a depigmenting agent
WO2008044636A1 (en) Anti-wrinkle agent and skin preparation for external use
AU2002256933A1 (en) A pharmaceutical composition for the treatment of seborrhea containing 4-hydroxy-5-methoxy-4-[2-methyl-3(3-methyl-2-butenyl)-2-oxiranyl]-1-oxaspiro[2,5]octan-6-one
TW202228748A (en) Method and compositions for skin microbiome normalization in sensitive skin
US20090232915A1 (en) Mixtures with a collagen synthesis boosting action
JP4575868B2 (en) Wrinkle improving agent, keratinization inhibitor, rough skin prevention / improving agent and pore reducing agent
KR20220082192A (en) Cosmetic composition for anti-oxidation, skin whitening, and improving of skin wrinkle containing Sanguisorba officinalis extract
KR101367703B1 (en) Composition of cosmetic and treating skin disease
JPH0987136A (en) Dermal preparation for external use
WO2016033899A1 (en) Dandruff removing composition for adjusting scalp oil balance
JPH03112912A (en) Cosmetic composition
KR100536550B1 (en) Composition containing moutan root bark extract as active ingredient
JPH107582A (en) Skin lotion
JP2004010505A (en) Cosmetic
JPH0977653A (en) Cosmetic
KR101460900B1 (en) Cosmetic composition for skin whitening, regeneration or moisturizing comprising epifriedelanol

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07829307

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07829307

Country of ref document: EP

Kind code of ref document: A1